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ABSTRACT
Lyme disease, the most common tick borne disease in United States, is caused
by the bacterial pathogen Borrelia burgdorferi. In nature, B. burgdorferi exists in an
enzootic infectious cycle between an arthropod vector and mammalian hosts.
Identification and characterization of the genes essential for B. burgdorferi survival
throughout its infectious cycle is an important step toward understanding the molecular
mechanisms involved in B. burgdorferi pathogenesis. B. burgdorferi contains a small
genome, which lacks the genes encoding for the enzymes required for de novo
synthesis of amino acids, fatty acids and nucleic acid precursors. Therefore, the
spirochete is dependent upon the host environment for the uptake of these essential
nutrients. Purines are required for the synthesis of nucleotides for the biosynthesis of
DNA and RNA. Due to the lack of de novo purine synthesis, the ability of B. burgdorferi
to salvage purines from its host environments is essential to its survival. While the
enzymes critical for the B. burgdorferi purine salvage pathway are known, the
transporters involved in the uptake of purines from the host environments are not. The
work in this thesis is focused on identification of the genes encoding purine permeases
in B. burgdorferi and genetic and biochemical characterization of their functions in the
infectious cycle of B. burgdorferi. Here, we demonstrate that homologous genes bbb22
and bbb23 present on circular plasmid 26 encode for purine permeases, which are
important for transport of hypoxanthine, adenine and guanine. Furthermore, genes
bbb22-23 together were essential for B. burgdorferi infection in mice. BBB22 and
BBB23 share 78% amino acid identify. And although, individually both BBB22 and
BBB23 were found to be capable of purine transport, BBB22 has higher affinity for
iii

hypoxanthine and adenine compared to BBB23. Moreover, the bbb22 gene alone was
sufficient to restore mouse infectivity to spirochetes lacking both bbb22 and bbb23,
whereas, bbb23 was not. Nonetheless, the spirochete loads in the tissues of mice
infected with B. burgdorferi carrying bbb22 alone were significantly reduced compared
to B. burgdorferi carrying both bbb22 and bbb23, demonstrating the importance of the
two genes together for the spirochetes to achieve wild type levels of infection. In ticks,
genes bbb22 and bbb23 were dispensable for spirochete survival but contributed to
spirochete replication in fed larvae. The replication of spirochetes lacking bbb22-23 in
larval ticks was restored to wild type levels by the reintroduction of the low affinity purine
transporter encoded by bbb23 alone. Overall, we have identified a purine transport
system in B. burgdorferi, which is essential for spirochete survival in the mammalian
host and contributes to spirochete replication in the tick vector. As B. burgdorferi lacks
typical virulence factors and toxins, these studies highlight the critical role of
physiological functions in the virulence of this pathogen. Moreover, the BBB22-23 in
vivo essential transport system may represent a novel therapeutic target to deliver
antimicrobial drugs to treat Lyme disease.
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CHAPTER 1: INTRODUCTION
1.1 Lyme disease, Pathophysiology, Prevalence, Diagnosis and Treatment
Lyme disease, first recognized in 1975, is a zoonotic disease and the most
prevalent tick borne infection in United States [1, 2]. Lyme disease is a multi-stage
inflammatory disease in the humans that affects the joints (arthritis), heart (carditis) and
nervous system (encephalitis) etc. According to recent reports from the Centers for
Disease Control and Prevention, approximately 300,000 cases of Lyme disease are
diagnosed every year which is 10 times higher than the actual number of cases
reported [3].
Lyme disease can be caused by a number of Borrelia species like B. burgdorferi,
B. afzelli, and B. garinii [4]. All these Borrelia species are together called as B.
burgdorferi senso lato. Among these, B. garinii and B. afzelli are endemic to Europe,
whereas B. burgdorferi is mainly distributed in North America [5]. In the United States
Lyme disease is most prevalent in the northeast and the upper midwest states.
Lyme disease pathogenesis has been classified into 3 stages: 1) early localized
infection, 2) early disseminated infection and 3) late disseminated infection [6]. Early
localized infection involves the inflammatory reaction at the site of tick bite on the skin
and the development of an erythema migrans (EM), a bulls eye rash most typically
characterized with Lyme disease [7]. This circular rash at the site of an infectious tick
bite is a result of inflammatory responses as spirochetes begin disseminating, creating
the appearance of a bull’s eye. Usually, the EM appears between 3 to 30 days after an
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infected tick feeding [8]. However, not every case of Lyme disease shows this bull’s eye
rash, and with only approximately 70-80% of the infected population developing EM [9].
Early localized infection also displays flu like symptoms such as fever, headache,
muscle pain and discomfort. History of a tick bite, an appearance of bull’s eye rash and
flu like symptoms together represent a symptomatic diagnosis of Lyme disease. During
early dissemination, spirochetes start moving from the original site of localized infection
to other tissues via blood circulation. At this stage, patients can develop EMs on other
parts of the body. Other more severe symptoms include signs of the nervous system
impairment like facial palsy, meningitis, memory loss and heart impairment (carditis)
and arthritic problems [10]. At late stage dissemination, the spirochetes are
disseminated into deep tissues. In these later stages spirochetes evade host immune
responses by decreasing the expression of immunogenic outer surface proteins [11, 12],
resulting in continued persistence of B. burgdorferi. At this point many organs such as
heart, joints, brain, and eyes start showing the late stage disease symptoms and can
lead to permanent functional impairments.
Lyme disease diagnosis is based upon the symptoms, tick bite history, and
serology analysis of B. burgdorferi specific antibodies. Since quantitative diagnosis is
dependent on antibody production, identification of an infection during the early stages
of an infection is difficult. Western blot and ELISA, are the two most commonly used lab
tests for the Lyme disease diagnosis. The CDC recommends two-tiered test that
includes an initial ELISA based assay and a followed by a western blot. The ELISA is a
sensitive but less specific assay. Positive ELISA results are confirmed by western blot,
which is more specific [13]. Levels of IgM and IgG-specific antibodies are measured to
2

diagnose Lyme disease. Antibiotic treatment of Lyme disease is successful if diagnosed
and treated in early stages of infection. In later stages of infection, while spirochetes are
killed by antibiotics, complete recovery may be hindered because of the inflammatory
damage that has already occurred as a result of the B. burgdorferi. Treatment of Lyme
disease depends upon many factors such as disease stage, age and immune system of
the patient. According to the CDC, patients diagnosed with Lyme disease and treated in
the early stages show complete recovery [14]. So, early diagnosis is a critical step in the
treatment of Lyme disease.
1.2 Borrelia burgdorferi and its infectious cycle
Borrelia burgdorferi is a bacterial pathogen, which causes Lyme disease in the
humans and animals [15]. The infectious cycle of B. burgdorferi includes a vertebrate
host, typically the white-footed mouse (Peromyscus leucopus), and a tick vector, mainly
Ixodes scapularis [16-19]. Ticks may also feed on the lizards, birds and small and large
mammals, all of which may contribute to the environmental reservoir of B. burgdorferi
(Figure 1). Hard ticks of the genus Ixodes are main ticks that transmit Lyme disease. I.
scapularis is the major tick vector that transmits Lyme disease in United States and is
most prevalent in the northeastern and midwestern United States. Ixodes pacificus
serves as the Lyme disease vector in California and other western states [20]. Ixodes
scapularis, also known as blacklegged tick or deer tick, has three life stages; larvae,
nymphs and adults. These ticks prefer warm and humid environments and feed only
once at each tick stage before molting to the next stage. Female adult stage ticks lay
eggs in the late spring, which hatch a few months later in the summer. Transovarial
transmission of spirochetes has not been demonstrated, so hatched larvae are not
3

infected with spirochetes and must feed on an infected host to acquire spirochetes [21].
Larvae mostly feed on the small mammals and birds and can acquire B. burgdorferi
from these infected hosts. Larval ticks subsequently transmit spirochetes to an
uninfected host during second and third blood meals as nymphal and adult ticks,
respectively. The fed larvae are approximately close to the size of mustard seed. The
larval stage ticks can survive for a long time even without a blood meal. Once they have
a blood meal, they molt into nymphs during the next spring. The nymphs have 8 legs
and they feed on the small and large mammals. Humans are more prone to Lyme
disease transmission by the nymphs [22] because of their small size and the tick
secretions released during the bite that prevents itching sensation [23]. Due to these
reasons, nymphs mostly remain undetected while feeding on humans and feed longer.
Nymphs, like all life stages of Ixodes scapularis, are slow feeders. The nymphs feed
continuously for 2-5 days depending upon the host blood circulation where the nymphs
are embedded. It takes 36-48 hours of tick feeding to start spirochete transmission to
the host [24]. After the blood meal, nymphs increase in size but these are still hard to
notice. Humans are not reservoir hosts for B. burgdorferi but acquire spirochetes
inadvertently when bitten by an infected tick [25]. Nymphal stage ticks show peak
activity in the summer months and at this time human exposure to the Lyme disease is
greatest. Fed nymphs molt into adult ticks during the fall. The adult ticks feed mostly on
the large mammals, typically deer [26]. Adult ticks mate and female ticks lay eggs in the
spring, all in all resulting in a two year life cycle.
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Figure 1. Infectious cycle of Borrelia burgdorferi.
Infectious cycle of B. burgdorferi includes a tick vector and multiple vertebrate hosts.
Adult female ticks lay eggs in the late spring. In summer, the larvae hatch from the eggs
and feed mostly on small vertebrate host. In next spring larvae molt into nymphs.
Nymphs feed on uninfected host and transmit Lyme disease to them. Human, not a
natural host for B. burgdorferi, but can acquire Lyme disease from nymphs. Nymphs
molt in to adult in Fall. Adult ticks further feed on next host and mate with adult male
ticks and hatch eggs in late spring [27].
Due to their motility and spiral morphology, B. burgdorferi is classified as a
spirochete and are placed in family Spirochaetaceae. Like other members of the family
Spirochaetaceae, B. burgdorferi possesses 7-11 flagella, which run along the entire
length of spirochete between the inner and outer membrane within the periplasmic
space [28]. As a result of the periplasmic localization of the flagella, B. burgdorferi move
in a corkscrew type motion [29]. This type of motility allows the spirochete to move
5

through viscous materials like connective tissue and the tick midgut. Although
categorized as gram negative bacteria, B. burgdorferi and other spirochetes are unique
in that these species lack lipopolysaccharide and do not stain gram negative in a gram
stain [30] . B. burgdorferi are 5-25 μm in length and 0.2-0.5 μm in width. They are
microaerophilic and have a slow in vitro replication time of approximately 6-8 hours
compared to the division times of other bacterial species such as E. coli (20 minutes)
[31], Bacillus subtilis (2 hours) [32] and Staphylococcus aureus (24 minutes) [33].
1.3 Borrelia burgdorferi genome
Compared to some other free-living bacteria, B. burgdorferi has a relatively small
and highly complex genome. B. burgdorferi contains one linear chromosome, 12 linear
plasmids and 9-11 circular plasmids [34-36] (Figure 2). The name of each plasmid
represents the approximate size of that particular plasmid in kilobase pairs. The size of
the linear chromosome is 910,725 base pairs [37]. Plasmid sizes vary from 5kb (linear
plasmid 25) to 56 kb (linear plasmid 56). Linear plasmids are 12 in number as following
lp5, lp17, lp21, lp25, lp28-1, lp28-2, lp28-3, lp28-4, lp36, lp38, lp54 and lp56. Circular
plasmids are 9-11 in number as following cp9, cp26, cp32-1, cp32-2, cp32-3, cp32-4,
cp32-5, cp32-6, cp32-7, cp32-8 and cp32-9 [38]. B. burgdorferi chromosome contains
853 open reading frames, among which the function for most of them is unknown. About
60% of these open reading frames are assigned some biological functions. 12% of
ORFs show identity to hypothetical proteins from other organisms and 29% of these
ORFs represent new genes with unknown functions.
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lp5
lp17
lp21
lp25
lp28-1

lp28-2

lp28-3

lp28-4

lp36
lp38
lp54
lp56
cp9
cp26

cp32 (1-9)
Linear Chromosome (910kb)

Figure 2. B. burgdorferi genome.
B. burgdorferi genome contains a linear chromosome, 12 linear plasmids and 9-11
circular plasmids. Linear chromosome is shown in blue, linear plasmids are shown in
green and circular plasmids are shown in yellow. The name of individual plasmid
represents the size of the plasmid [38].
Sequence analysis of plasmids reveals that 175 gene families, mostly unique to
the Borrelia species and very few genes have predicted function. About 60% of genes
found on B. burgdorferi plasmids are not present in the other organisms and are unique
to Borrelia. Actual coding sequences on plasmid comprise 71% of the total plasmid
DNA, which is less compared to the chromosome. This decreased coding sequence
compared to the linear chromosome suggests these plasmids contain longer non-
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coding inter-genic sequences. Each plasmid in B. burgdorferi B31 strain contains genes
predicted to be essential for plasmid replication and compatibility. The number of these
genes vary from 1-4 with most of the plasmids having a set of 4 genes [39].
B. burgdorferi has the capacity to lose plasmids during in vitro propagation, and
the infection studies with high passage spirochetes show that the loss particular
plasmids correlates with the loss of pathogenicity [40]. This was the first evidence that
B. burgdorferi contains the plasmid encoded genes essential for the mouse infection.
Some of the plasmids are ubiquitous and can never be lost by B. burgdorferi, like the
circular plasmid 26 [41]. Some of the genes present on B. burgdorferi plasmids
represent physiological functions. The presence of some plasmids like lp25 and lp56
make Borrelia burgdorferi transformation very difficult [42]. These plasmids contain
genes that encode restriction and/or modification system that may result in the low B.
burgdorferi transformation frequencies [42]. It was later found that a gene bbe02
present on lp25 makes B. burgdorferi transformation difficult and knocking out just
bbe02 from lp25 and bbq67 from lp56, makes the B. burgdorferi transformation easier
[42].
Some of the genes on the B. burgdorferi plasmids are essential for mouse
infection such as guaA, guaB [43], bbb26 and bbb27 [41] on cp26, pncA on lp25 and
bbk17 on lp36. bbe22 alone can restore mouse infectivity when added back to
spirochetes missing the entire lp25 plasmid suggests other genes on lp25 are not
essential for mouse infection [44, 45]. bbe16, another gene on lp25, is required for tick
colonization [46]. lp28-1 is one of the linear plasmids, absence of which leads to the
reduced B. burgdorferi infectivity in mice [47]. lp28-1 contains VMP like sequence (vls)
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which is involved in the antigenic variation [48]. So, if this plasmid is missing,
spirochetes will not able to modifiy antigens to escape the host immune response [48,
49].
B. burgdorferi genes show differential expression with changes in the
environment [50]. Throughout the complex infectious cycle of B. burgdorferi, which
involves various hosts like small rodents, lizards, birds and large mammals and a tick
vector, the spirochetes are exposed to the different environmental stresses
(i.e.,differences in temperature, pH and nutrients). In ticks, spirochetes reside in the
midgut, which has basic pH and a temperature of ~25°C [51]. In the mammalian host,
blood pH is almost neutral and the temperature is 37°C [52]. To overcome these basic
environmental differences, B. burgdorferi regulates its gene expression in response to
each host. In particular B. burgdorferi alters expression of its outer surface proteins in
response to distinct environmental signals [53, 54]. Spirochetes express outer surface
proteins for dissemination, virulence and immune evasion [55]. OspA is an outer surface
protein of B. burgdorferi, which helps B. burgdorferi to colonize in the tick midgut [25].
Upon a blood meal, spirochetes begin downregulating the production of OspA and
increasing production of the mammalian specific OspC [54]. The blood meal serves as
the trigger of a genetic switch in the tick colonized B. burgdorferi, altering the pH and
temperature of the midgut environment.
Many of the molecular mechanisms of B. burgdorferi pathogenesis remain
unknown. B. burgdorferi is not known to produce toxins but is still able to penetrate host
tissues and cause infection [37, 39]. To understand B. burgdorferi pathogenesis in
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depth, it is important to study the molecular mechanisms involved in the survival of
these spirochetes in different host environments.
B. burgdorferi has a reduced genome that lacks the genes required for the
synthesis of necessary biological molecules such as amino acids, fatty acids, enzyme
co-factors and nucleotides [56]. Due to the lack of biosynthetic pathways, B. burgdorferi
depends upon the host environment for the uptake of these essential nutrients [36, 43,
57, 58]. Barbour Stoenner Kelli II (BSKII) culture media is used for in vitro growth of B.
burgdorferi. This media is highly rich in nutrients and is supplemented with the rabbit
serum. A variety of genetic studies have shown that various plasmid encoded genes
play essential roles in the nutrient acquisition. The guaA and guaB genes present on
circular plasmid 26 encode for GMP synthase and IMP dehydrogenase respectively,
which play an essential role in the B. burgdorferi purine salvage pathway [43]. PncA on
bbe22 (lp25) encodes for a nicotinamidase and is required for the biosynthesis of NAD
[59, 60].
1.4 Purine metabolism
Purines and pyrimidines are the nucleotide base components of
deoxyribonucleotides and nucleotides, which are the building blocks of DNA and RNA,
respectively [56]. Each nucleotide is composed of a nitrogenous base that can be a
purine (adenine, guanine) or pyrimidine (cytosine, thymidine), a five-carbon sugar
(oxyribose for RNA, deoxyribose for DNA) and a phosphate group. The number of
phosphate groups can vary between 1-3, depending upon the nucleotide e.g.
nucleotides used in cell signaling like cAMP, cGMP have one phosphate group,
whereas nucleotides playing role in the metabolism such as ATP, GTP CTP and UTP
10

are having three phosphate groups [61]. Nucleic acid contains five nucleobases such as
adenine, guanine, thymidine, cytosine and uracil, among which adenine and guanine
are classified as purines. Hypoxanthine is a purine derivative that is converted into IMP
in the nucleotide biosynthesis pathway [43]. Purines consist of a pyrimidine ring and an
imidazole ring. Apart from their crucial role in the DNA and RNA synthesis, purines are
also important components of other biomolecules such as ATP, GTP as energy sources,
cAMP as secondary messenger in biological processes and NADH as coenzyme in
living cells [61-63].
Nucleotides are critical for the survival of all living cells and can be synthesized
either de novo or through the purine salvage pathways. Ammonia, CO 2 and amino acids,
serve as sources for the components used in the synthesis of these nucleotides. During
the process of DNA and RNA synthesis, some nucleic acids undergo repair and
degrade into purines and pyrimidine. It has been shown in some bacteria, like
Helicobacter pylori, that the mechanisms for de novo nucleotide synthesis are absent,
requiring purines for nucleic acid synthesis [64-67]. Purine metabolism is critical for the
virulence of most of the bacterial pathogens in the mammalian host [68-70].
Degradation of the host DNA can serve as purine sources for bacterial pathogens [65].
1.5 Purine salvage in Borrelia species
Borrelia species have a reduced genome and lack de novo synthesis of purines
to biosynthesize nucleotides. As a result, Borrelia species are dependent upon the host
environments for purine and pyrimidine salvage. Borrelia species differ in these salvage
pathways. B. burgdorferi, B. afzelli and B. garinii genomes lack genes involved in
classic purine salvage pathway such as purA (adenylosuccinate synthase), purB
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(adenylosuccinate lyase), hpt (hypoxanthine-guanine phosphoribosyltransferase), nrdI
(auxiliary protein), nrdE (ribonucleotide-diphosphase reductase alpha subunit), nrdF
(ribonucleotide-diphosphase reductase beta subunit), and a locus encoding
ribonucleotide reductase (RNR) [37, 56, 71-73]. While, the relapsing fever spirochetes,
Borrelia hermsii and B. turicatae possess all these genes. Ribonucleotide reductase,
present in Borrelia hermsii, synthesizes deoxynucleotides to be utilized in DNA
synthesis [73]. B. burgdorferi lacks RNR, and therefore requires either external sources
of deoxyribonucleosides or alternative pathways to synthesize them. B. burgdorferi has
a unique enzyme called deoxyribosyltransferase encoded by bb0426 that is involved in
the transfer of a deoxyribosyl moiety from deoxynucleosides to hypoxanthine to convert
it into deoxyinosine (dI), and another enzyme deoxynucleotide kinase to convert dI into
dIMP to synthesize DNA (Figure 3). Likewise, B. burgdorferi lacks purA and purB genes,
so hypoxanthine utilization is limited to the synthesis of dGMP and GMP, unlike in B.
hermsii, where hypoxanthine can also be utilized in the synthesis of dAMP and AMP.
This suggests a requirement for host driven adenine nucleosides in B. burgdorferi, but
not in B. hermsii. Phosphoribosyl transferase (PRT) transfers a phosphate group to a
purine base for the synthesis of nucleoside monophosphates such as AMP, GMP, IMP
or XMP [56]. Inosine monophosphate (IMP) is an important intermediate for the
biosynthesis of nucleotides like AMP and GMP [43, 56]. Previous studies have shown
that PRT activity in B. hermsii is 7 fold higher than in B. burgdorferi [73]. B. hermsii PRT
has a similar activity for hypoxanthine and guanine, whereas B. burgdorferi does not
have PRT activity with the guanine substrates little activity with hypoxanthine [73].
Rather, B. burgdorferi has an adenine deaminase enzyme, lacking from B. hermsii, that
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converts adenine into hypoxanthine [57], which is then believed to be converted to IMP
by PRT [56]. Due to high hypoxanthine-PRT activity in B. hermsii, direct incorporated
hypoxanthine is sufficient to get converted into IMP. It has been observed that B.
hermsii incorporate 9 fold higher hypoxanthine compared to B. burgdorferi [73].
Hypoxanthine is the most abundant purine in human plasma compared to the other
purine bases, with hypoxanthine at 8.2 ± 1.3uM, xanthine at 2.5 ± 0.6uM, adenine at 0.3
± 0.15uM and adenosine at0.6 ± 0.2uM) [74]. This most likely attributes to higher
hypoxanthine PRT activity in B. hermsii compared to B. burgdorferi, as relapsing fever
spirochetes have ability to achieve very high concentrations in blood by scavanging the
available hypoxanthine [73].
Even though B. burgdorferi lacks some of the enzymes involved in the classic
purine salvage pathways, these spirochetes are still able to salvage purines from the
host environment and are able to survive in the host. B. burgdorferi possess IMP
dehydrogenase (GuaB) and GMP synthase (GuaA), which are two critical enzymes in
purine salvage pathways (Figure 3) [43]. GuaA and GuaB are essential for the survival
of B. burgdorferi in a mouse and play an important role in the spirochete growth in the
tick vector [43]. Also, in conditions of stress, the enzymatic activities of GuaA and GuaB
are sufficient to synthesize GMP and dGMP, even when deoxyguanine nucleosides are
low [73]. In vitro transport assays have shown that B. burgdorferi transport
deoxynucleotides (dCMP, dGMP and dAMP) and oxynucleotides (CMP, GMP and
AMP) that are incorporated into the DNA and RNA, respectively [56].
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Figure 3. Novel purine salvage pathway in B. burgdorferi.
Adenine, hypoxanthine and guanine are transported from the host environment through
unknown purine transporter/s. Once these purines are incorporated into the cytoplasm,
adenine is converted into hypoxanthine by adenine deaminase [43, 56, 73].
Hypoxanthine is converted into IMP by phosphoribosyltransferase [43, 56].
Hypoxanthine to dIMP conversion involves deoxyribosyltransferase followed by
deoxynucleotide kinase. IMP is further converted into GMP through IMP dehydrogenase
(GuaB) and GMP synthase (GuaA). GMP and dGMP are utilized in the synthesis of
RNA and DNA, respectively. B. burgdorferi also uptakes nucleotides and
deoxynucleotides which are dephosphorylated prior to transport. Later these
nucleosides and deoxynucleosides are phosphorylated again and are directly utilized in
the synthesis of RNA and DNA. Deoxynucleosides also serve as a source of deoxy
group to hypoxanthine to synthesize deoxyinosine [56].
1.6 Purine Transporters
Uptake of purines from the external environment can be important for cell
survival, as these purines can be utilized as building blocks for DNA and RNA [56], or
as carbon and nitrogen metabolic sources [75]. Specific membrane transport proteins
are required to bring purines into the cell. The nucleobase/ascorbate transporter (NAT)
family includes prokaryotic membrane transport proteins for purines and pyrimidines
and eukaryotic ascorbate transport proteins [76, 77]. In mammals, NAT transporters are
sodium symporters, whereas in bacteria these are proton symporter [77-79]. Bacterial
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and fungal putative purine transporters fall under one of the two nucleobase cation
symporter families nucleobase cation symporter 1 (NCS1) and nucleobase cation
symporter 2 (NCS2). To date only a few purine transporters have been functionally
characterized, with the majority belonging to the NCS2 family [80]. The NCS2
superfamily contains two clusters, COG2233 and COG2252. COG2233 cluster contains
well studied permeases for xanthine and/or uric acid permeases, like xanthine
permease (XanQ) of E. coli [80], uric acid permease (UacT) of E. coli [80], and
xanthine/uric acid permease (UapA) of Aspergillus nidulans [80, 81]. COG2252 cluster
contains purine transporters for hypoxanthine, adenine and guanine [80]. AzgA is a
purine transporter of Aspergillus nidulans, which transports hypoxanthine, adenine and
guanine [82]. It was the first characterized member of the membrane proteins [82]. E.
coli contains four purine transport proteins that are similar in sequence to AzgA and
characterized under the COG2252 cluster, PurP, YjcD, YgfO and YicO [80]. YjcD and
YgfQ are high affinity hypoxanthine-guanine permeases and PurP and YicO are high
affinity adenine permeases [80]. Bacillus subtilis contains two purine transporters PbuO
and PbuG under COG2252 cluster. Both PbuO and PbuG are hypoxanthine-guanine
permeases [80]. Borrelia burgdorferi lacks the genes required for the de novo synthesis
of purines and to date, no purine transporters have been functionally characterized in
any of the Borrelia species.
1.7 Unique features of circular plasmid 26 in B. burgdorferi
The circular plasmid 26, unlike some of the other circular plasmids, has never been
observed to be lost through in vitro passaging of B. burgdorferi cultures [41, 83-85]. This
suggests cp26 contains the genes essential for the survival of these spirochetes. There
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are 29 ORFs present on cp26 and 14 of these show sequence homology with the genes
from other organisms with known functions. The resT gene present on cp26 encodes for
a telomere resolvase, which is required for resolution of the replicated telomeres of
linear chromosome and linear plasmids [36]. Similarly, bbb18, bbb17, and bbb19
encoding GuaA, GuaB, and OspC, respectively, are essential for spirochete survival in
the mouse [43, 86]. As B. burgdorferi lacks de novo synthesis of purines, so it is
dependent on purine salvage from the host environment. Purine permeases
transporting these purines into B. burgdorferi are yet unknown. Genes bbb22 and bbb23
present adjacent to each other on cp26 are annotated to encode putative xanthine/uracil
permeases under nucleobase cation symporter 2 (NCS2) family.
1.8 Hypothesis
The transport activities of the proteins encoded by bbb22 and bbb23 play a critical role
in Borrelia burgdorferi survival and/or growth in an infectious cycle between the
mammalian host and tick vector due to their roles in purine salvage.
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CHAPTER 2: BORRELIA BURGDORFERI HARBORS A TRANSPORT SYSTEM
ESSENTIAL FOR PURINE SALVAGE AND MAMMALIAN INFECTION
2.1 Preface
The first complete draft of the chapter was written by SJ. Comments from MWJ
and reviewers were incorporated into the final version presented here. This chapter was
published previously and is reprinted here with permission. Copyright © American
Society for Microbiology, Jain S., Sutchu S., Rosa PA., Byram R. and Jewett MW. 2012.
Borrelia burgdorferi harbors a transport system essential for purine salvage and
mammalian infection. Infection and Immunity. 80(9):3086-93. DOI: 10.1128/IAI.0051412.
2.2 Abstract
Borrelia burgdorferi is the tick borne bacterium that causes the multistage
inflammatory disease, Lyme disease. B. burgdorferi has a reduced genome and lacks
the enzymes required for de novo synthesis of purines for synthesis of RNA and DNA.
Therefore, this obligate pathogen is dependent upon the tick vector and mammalian
host environments for salvage of purine bases for nucleic acid biosynthesis. This
pathway is vital for B. burgdorferi survival throughout its infectious cycle as key
enzymes in the purine salvage pathway are essential for the ability of the spirochete to
infect mice and critical for spirochete replication in the tick. The transport of pre-formed
purines into the spirochete is the first step in the purine salvage pathway and may
represent a novel therapeutic target and/or means to deliver anti-spirochete molecules
to the pathogen. However, the transport systems critical for purine salvage by B.
burgdorferi have yet to be identified. Herein, we demonstrate that genes bbb22 and
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bbb23 present on B. burgdorferi’s essential plasmid circular plasmid 26 (cp26) encode
key purine transport proteins. BBB22 and/or BBB23 are essential for hypoxanthine
transport and contribute to the transport of adenine and guanine. Furthermore, B.
burgdorferi lacking bbb22-23 were non-infectious in mice up to a dose of 1x107
spirochetes. Together our data establish that bbb22-23 encode purine permeases
critical for B. burgdorferi mammalian infectivity, suggesting that this transport system
may serve as a novel anti-microbial target for the treatment of Lyme disease.
2.3 Introduction
Borrelia burgdorferi, the pathogenic spirochete that causes Lyme disease, is an
obligate parasite that cycles in nature between the tick vector, Ixodes sp., and
mammalian host, typically a small rodent. Transmission of B. burgdorferi to humans by
tick bite, although not part of the zoonotic infectious cycle of the spirochete, results in
Lyme disease. Unlike many other bacterial pathogens, B. burgdorferi is not known to
harbor classic virulence factors, such as toxins or secretion systems to deliver bacterial
effector molecules [35, 37]. Clinical manifestations associated with Lyme disease are
believed to result from the immune response to the spirochetal infection [87]. Therefore,
genes encoding physiological functions that allow for growth within the infected host are
important virulence determinants [43, 57, 60], as survival is a critical component of B.
burgdorferi pathogenesis.
B. burgdorferi lacks the enzymes required for de novo synthesis of purines and
therefore relies absolutely upon salvage of purines from its environment for nucleic acid
biosynthesis [43, 56, 73, 88]. B. burgdorferi has evolved a novel purine salvage
pathway that in addition to scavenge of purine bases, involves the salvage of
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deoxynucleotides from the host environment. Purine metabolism in B. burgdorferi also
utilizes interconversion of purine bases to deoxynucleosides by the deoxyribosyl
transferase BB0426, and the catalysis of inosine monophosphate (IMP) to guanosine
monophosphate (GMP), and deoxyinosine monophosphate (dIMP) to deoxyguanosine
monophosphate (dGMP), by GuaA and GuaB, respectively [56]. This pathway is vital
for B. burgdorferi survival throughout its infectious cycle as key enzymes in this purine
salvage pathway are essential for the ability of the spirochete to infect mice and critical
for spirochete replication in the tick [43, 57]. The transport of pre-formed purines into
the spirochete represents the first step in the purine salvage pathway; however, the
transport systems critical for purine salvage by B. burgdorferi have yet to be identified.
Circular plasmid 26 (cp26) is the only plasmid that is present in all B. burgdorferi
isolates examined to date and is not lost during in vitro propagation. This plasmid
carries genes essential for survival of the spirochete during both in vitro and in vivo
growth [36, 41]. Cp26 harbors the essential gene resT, which encodes the telomere
resolvase required for replication of linear plasmids and the linear chromosome [36],
and the ospC gene, which is critical for mammalian infection [86, 89-91]. Furthermore,
cp26 carries the genes encoding IMP dehydrogenase (GuaB) and GMP synthase
(GuaA), two key enzymes in the B. burgdorferi purine salvage pathway, as described
above [43, 56, 92]. In addition to genes involved in peptide transport (oppAIV) [58],
chitobiose transport (chbA, chbB and chbC) [93] and glucose transport (bbb29) [36],
cp26 harbors two adjacent genes, bbb22 and bbb23, both of which are hypothesized to
encode putative purine permeases [36].
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Herein we establish that the BBB22 and BBB23 proteins function to transport
hypoxanthine, adenine and guanine. Moreover, our results demonstrate that this
transport system is absolutely required for survival of B. burgdorferi during mammalian
infection.
2.4 Materials and methods
2.4.1: Bacteria clones and growth conditions.
All low-passage B. burgdorferi clones were derived from infectious clone A368BBE02, which lacks cp9, lp56 and gene bbe02 on lp25 [94]. B. burgdorferi was
grown in liquid Barbour-Stoenner-Kelly (BSK) II medium supplemented with gelatin and
6% rabbit serum [95] and plated in solid BSK medium as previously described [96, 97].
All spirochete cultures were grown at 35°C supplemented with 2.5% CO2. Kanamycin
was used at 200g/ml, streptomycin at 50g/ml and gentamicin at 40g/ml, when
appropriate. All cloning steps were carried out using DH5α E. coli. E. coli cultures were
grown in LB broth or on LB agar plates containing 50g/ml kanamycin, 300g/ml
spectinomycin or 10g/ml gentamycin.
2.4.2: Deletion of bbb22-23.
A 3.8 kb DNA fragment encompassing the BBB22 and BBB23 ORFs along with
500 bp flanking region from both sides was amplified from the B. burgdorferi B31 clone
A3 genomic DNA using the Expand Long PCR system (Roche) and primers 1 and 2
(Table 1) and was cloned into the TOPO XL vector (Invitrogen), creating plasmid TOPO
XL bbb22-23+500. The 2.8 kb DNA sequence encoding the BBB22 and BBB23 ORFs
was removed by inverse PCR using the Expand Long PCR system (Roche) and primers
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7 and 8, generating linear pbbb22-23 with SalI ends. Spectinomycin/streptomycin
resistance cassette, flaBp-aadA [41] with XhoI ends, was amplified using Taq
polymerase and primers 3 and 4. The flaBp-aadA product was treated with XhoI and
ligated with SalI and DpnI-digested linear pbbb22-23, yielding the allelic exchange
plasmid pbbb22-23-flaBp-aadA. B. burgdorferi A3-68BBE02 was transformed with
20ug of pbbb22-23-flaBp-aadA purified from E. coli as previously described [97-99].
Streptomycin-resistant colonies were confirmed to be true transformants by PCR using
primer pairs 1 and 2 and 5 and 6. Positive bbb22-23-flaBp-aadA clones were
screened with a panel of primers for the presence of all of the B. burgdorferi plasmids of
the parent A3-68BBE02 clone [94], and a single clone was selected for further
experiments.
2.4.3: Complementation of the bbb22-23 mutant.
A DNA fragment encompassing the bbb22-23 genes and upstream putative
promoter sequence was amplified from B31 A3 genomic DNA using Phusion enzyme
(Thermo Scientific) and primers 5 and 6 (Table 1), which introduced BamHI and HindIII
sites at the 5’ and 3’ ends, respectively. The BamHI+HindIII-digested PCR product was
ligated into BamHI+HindIII-cut B. burgdorferi shuttle vector pBSV2G [98]. The plasmid
structure and sequence were confirmed by restriction digest and DNA sequence
analysis. The bbb22-23 mutant was transformed with 20 µg of pBSV2G bbb22-23 or
pBSV2G isolated from E. coli and positive transformants selected as previously
described [57]. The clones that retained the B. burgdorferi plasmid content of the
parent clone were selected for use in further experiments.
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2.4.4: In vitro growth analysis.
Wild type (A3-68BBE02), ∆bbb22-23/vector and ∆bbb22-23/bbb22-23+
spirochetes were inoculated in triplicate at a density of 105 spirochetes/ml in 5 ml of
BSK II medium. Spirochete densities were determined every 24 hours under dark field
microscopy using a Petroff-Hausser chamber over the course of 96 hours.
2.4.5: RNA isolation from in vitro grown spirochetes.
Wild type (B31 A3) spirochetes were grown in triplicate in 5 ml of BSKII pH7.5 at
35C to a density of 2x108 spirochetes/ml. A total of 1x107 spirochetes was harvested
from each culture and resuspended in 25 µl of RNAlater (Life Technologies) and stored
at -80C until processing. Total RNA was isolated using TRIzol reagent (Life
Technologies) according to the manufacturer’s instructions. RNA was resuspended in
100 µl DEPC-treated dH2O. RNA was treated with TURBO DNAse (Life Technologies)
to remove any contaminating genomic DNA. 1 µl of Riboguard (40U/µl) RNAse inhibitor
(Epicentre) was added to all samples and RNA stored at -80C.
2.4.6: RNA isolation from infected mouse tissue.
B. burgdorferi infected mouse hearts (see Mouse infection experiments below)
were manually macerated on ice using sterile scalpels and transferred to a 2 ml tube
containing lysing Matrix D (MP Biomedicals). 1 ml of RNA pro solution (FastRNA Pro
Green kit, MP Biomedicals) was added to each sample on ice. Tissues were
homogenized using a PowerGen High-Throughput Homogenizer (Fisher Scientific)
following six cycles of beating for 45 sec and 2 minutes on ice. Samples were
centrifuged at 13,000 rpm for 5 minutes at 4C. The upper aqueous phase was
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transferred to new tubes and incubated for 5 minutes at room temperature. 500 µl of 1bromo-3-chloropropane (Sigma) and 45 µl of 5M sodium acetate were added to each
sample and samples were incubated for an additional 5 minutes at room temperature.
Samples were centrifuged at 13,000 rpm for 5 minutes at 4C. The upper aqueous
phase was transferred to new tubes and RNA precipitated with the addition of 500 µl of
absolute ethanol and 1 µl of GlycoBlue (Life technologies). RNA was pelleted by
centrifugation at 13,000 rpm for 10 minutes at 4C. RNA was washed with 70% ethanol
in DEPC treated-H20 and resuspended in 100 µl of DEPC treated-H20. RNA was
treated with TURBO DNAse (Life Technologies) to remove any contaminating genomic
DNA. 1 µl of Riboguard (40U/ µl) RNAse inhibitor (Epicentre) was added to all samples
and RNA stored at -80C.
2.4.7: Gene expression analysis.
cDNA was synthesized from all RNA samples using the qScript Flex cDNA
synthesis kit (Quanta BioSciences) with random hexamer primers according to the
manufacturer’s instructions. Parallel cDNA reactions were carried out in the absence of
reverse transcriptase. Real-time quantitative PCR (qPCR) reactions were prepared

Biosystems 7500 instrument, samples were assayed for the flaB [43], bbb22 and bbb23
transcripts using primers pairs 13 and 14 and 15 and 16, respectively (Table 1) and
probes 17 and 18, respectively (Table 1). The flaB transcript was used as the
endogenous reference to which the transcripts of the target genes were normalized.
The bbb22 and bbb23 primers were confirmed to be specific for their respective gene
targets. The amounts of the flaB, bbb22 and bbb23 transcripts were determined using a
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standard curve for each gene target that was generated using genomic DNA isolated
from 106,105, 104, 103, 102 and 101 spirochetes. Samples were analyzed in triplicate
with at least two biological replicates and gene expression reported as the number of
gene transcripts per flaB mRNA copy. The amplification of samples lacking reverse
transcriptase was similar to that of the no-template control. Data sets were compared
using the nonparametric Kruskal-Wallis test with Dunn’s multiple-comparison test using
GraphPad Prism 5.0 for Windows (GraphPad Software).
2.4.8: Radioactive transport assays.
B. burgdorferi clones were grown in 40 ml of BSKII to a density of 8 x 107
spirochetes/ml, washed twice with HN buffer (50 mM Hepes, 50 mM NaCl, pH 7.6) and
resuspended in a final volume of 2.5 ml of HN buffer. 500 µl (~ 5x108 spirochetes)
aliquots of spirochetes were combined with 20 µl of 300 mM glucose (6 mM final
concentration) and an additional 480 µl of HN buffer. Spirochetes were preincubated at
37C for 30 minutes. 250 nM [3H]hypoxanthine monohydrochloride (specific activity 20
Ci/mmol) (Perkin Elmer) or 33 nM [2,8-3H]adenine (specific activity 30 Ci/mmol) (Perkin
Elmer) was added to the reaction and 100 µl aliquots of the reaction (5x107 spirochetes)
were removed at various time points following the addition of radioactivity and filtered
onto cellulose acetate filter membranes using a 10 place filtration manifold (Hoefer, Inc.)
and immediately washed with 10 ml of HN buffer. Filter-bound spirochetes were
collected in scintillation vials containing 3ml of ScintiVerse BD cocktail scintillation fluid
(Fisher Scientific) and radioactivity counted in a Microbeta2 with an efficiency of 52%
(Perkin Elmer). The rates of uptake of hypoxanthine and adenine (picomoles/10 7
spirochetes/minute) were calculated by first converting CPMs to picomoles assuming 1
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CPM = disintegrations per minute (dpm) x an efficiency of .52 and 1 Ci = 2.2x10 12 dpm.
The rates corresponding to the time points for the linear portion of each uptake curve
were averaged to determine the average rate of uptake.
Spirochetes for [3H]hypoxanthine monohydrochloride uptake assays in the
presence of cold competitors were grown and prepared as described above. 1 mM
stock solutions of each cold competitor: hypoxanthine, adenine, guanine, xanthine,
cytosine, thymine, uracil, ascorbic acid, and 5’-deoxy-5’-(methylthio)adenosine (MTA)
were prepared in 8 mM NaOH. Reactions were initiated with the addit
competitor (50 µM final concentration, 200-fold excess) or 50 µl of 8 mM NaOH alone
and 250 nM [3H]hypoxanthine monohydrochloride. A 100 µl aliquot (5x107 spirochetes)
of each reaction was removed 10 minutes following the addition of radioactivity and
filtered onto cellulose acetate filter membranes using a 10 place filtration manifold
(Hoefer, Inc.) and immediately washed with 10 ml of HN buffer. Filter-bound
spirochetes were collected in scintillation vials containing 3ml of ScintiVerse BD cocktail
scintillation fluid (Fisher Scientific) and radioactivity counted in a Microbeta 2 (Perkin
Elmer). A3-68BBE02 and A3-68BBE02 heated to 95C for 10 minutes served as the
wild type control and the heat killed negative control, respectively, for all transport
assays. Each transport assay was repeated in triplicate.
2.4.9: Mouse infection experiments.
The University of Central Florida (UCF) is accredited by the International
Association for Assessment and Accreditation of Laboratory Animal Care. Protocols for
all animal experiments were prepared according to the guidelines of the National
Institutes of Health and approved by UCF’s Institutional Animal Care and Use
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Committee. For gene expression studies, four mice (C3H/HeN, 6-8 week old females,
Harlan) were needle inoculated, 80% intraperitoneal and 20% subcutaneous, with B.
burgdorferi clone B31 A3 at a dose of 1x105 spirochetes. For infectivity studies, groups
of 6 mice each (C3H/HeN, 6-8 week old females, Harlan) were needle inoculated, 80%
intraperitoneal and 20% subcutaneous, with clone bbb22-23/vector or bbb2223/bbb22-23+ at a dose of 1x104 or 1x107 spirochetes. The number of spirochetes
inoculated into mice was determined using a Petroff-Hausser counting chamber and
verified by colony-forming unit (cfu) counts in solid BSK medium. Ten colonies per
inoculum were verified by PCR for the presence of the virulence plasmids lp25, lp28-1
and lp36 in at least 90% of the individuals in the population. Further, total plasmid
content of each inoculum was confirmed to be as expected [57]. Mouse infection was
assessed three weeks post inoculation by serology and reisolation of spirochetes from
ear, bladder and joint tissues, as previously described [57]. Heart tissues were
harvested from B31 A3 inoculated mice for RNA isolation and gene expression studies.
2.5 Results
2.5.1: The BBB22 and BBB23 open reading frames on cp26.
The BBB22 and BBB23 open reading frames (ORFs) are in the same orientation
and separated by 109 bp [35, 37]. The bbb22 and bbb23 genes (1356 bps and 1392
bps, respectively) and their annotated proteins (451 amino acids and 463 amino acids,
respectively) are 79.8% and 78.3 % identical at the nucleotide and amino acid levels,
respectively, suggesting that these genes may be paralogs and their encoded proteins
may have overlapping functions in B. burgdorferi. Both BBB22 and BBB23 are
annotated as guanine/xanthine permeases and have a conserved domain COG2252
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(xanthine/uracil/vitamin C permease) that is a distant subfamily of the NCBI CD
superfamily cI00967 NAT (Nucleobase/Ascorbate Transporter) family [100]. BBB22 and
BBB23, similar to other COG2252 domain proteins, are predicted to both localize to the
bacterial inner membrane and contain 12 transmembrane domains [82, 101-104] (Fig.
4). Current annotation of the BBB23 ORF suggests that translation of the BBB23
protein initiates at the alternative start codon TTG and produces a 463 amino acid
protein that is 12 amino acids longer than the predicted 451 amino acid size for the
BBB22 protein [35, 37] (Fig. 4). Upon further analysis of the BBB23 ORF sequence, we
identified an ATG start codon 36 nucleotides within the current annotation of the BBB23
ORF, which is preceded by a reasonable Shine-Dalgarno sequence five base pairs
upstream. Our prediction of this ATG residue as the putative true start codon for the
BBB23 protein resulted in the additional prediction that the BBB23 ORF produces a 451
amino acids protein, as is predicted for BBB22.
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Figure 4. The BBB22 and BBB23 proteins demonstrate a high level of identity.
Shown is an amino acid alignment of the BBB22 (NP_047008.1) and BBB23
(NP_047009.2) proteins, according to current annotation. Identical amino acids are
shaded. Amino acid sequences were aligned using the Clustal W algorithm in the
MegAlign program from the DNASTAR Lasergene suite. The putative sequences of the
12 transmembrane domains were predicted using the TMHMM Server v. 2.0 [105] and
are indicated with gray underlines. Divergent sequences in putative periplasmic loops 4
and 6 are indicated with black underlines. An alternative prediction for the start codon
of BBB23 is indicated with a black arrow.
2.5.2: The bbb22-23 genes are essential for B. burgdorferi mouse infectivity.
Given the high degree of amino acid identity between the BBB22 and BBB23
proteins, it is reasonable to predict that these two proteins could have overlapping
functions and in the absence of one, the other may be able to functionally compensate.
Moreover, we have found that both genes are expressed during mammalian infection
(Fig. 5), suggesting that both proteins may be important for survival in the mouse.
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Figure 5. The bbb22 and bbb23 genes are expressed during murine infection.
Spirochete RNA was isolated from log phase (3x107 spirochetes/ml) B. burgdorferi
clone B31 A3 grown in BSKII medium, pH 7.5 at 35C (in vitro). Total RNA was isolated
from spirochete infected heart tissue harvested 2 weeks post intradermal inoculation of
C3H/HeN mice with 1x105 B. burgdorferi clone B31 A3 (in vivo). Expression of genes
flaB, bbb22 and bbb23 was quantified by reverse transcriptase qPCR. The data are
expressed as the number of bbb22 (open bars) or bbb23 (gray bars) gene transcripts
per flaB mRNA copies. The in vitro data represent the average of two biological
replicates. The in vivo data represent the average of four biological replicates. Error
bars represent the standard deviation from the mean. All data sets were compared
pairwise using the Kruskal-Wallis nonparametric rank test followed by Dunn’s multiplecomparison test (GraphPad Prism 5.0) and were found to have no statistical difference.

Therefore, in order to examine the combined functional role of the BBB22 and
BBB23 proteins during mammalian infection, the sequence encompassing both open
reading frames was deleted from low passage, infectious B. burgdorferi and replaced
with the flaBp-aadA spectinomycin/streptomycin resistance cassette [41] by allelic
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exchange (Fig. 6). Successful recovery of bbb22-23 spirochetes demonstrates that
the function of the encoded proteins is not essential for B. burgdorferi survival in in vitro.
The bbb22-23 spirochetes were genetically complemented in trans on the shuttle
vector pBSV2G with wild type copies of the bbb22 and bbb23 genes and102 bps of 5’
flanking sequence encompassing the presumed promoter [98]. In vitro growth analysis
demonstrated no difference in growth between bbb22-23, bbb22-23/bbb22-23+ and
wild type spirochetes over the course of 96 hours (data not shown), suggesting that the
function of the gene products are not required for spirochete replication in nutrient rich
BSKII in vitro growth medium.
Table 1: List of primers and probes used in this study.
Primer/Probe

Designation

Sequence (5’-3’)

1

BBB22 -500

CAGTTAAAGAGCTTACAAGCCC

2

BBB23 + 500

AGGATACCTTGCAATATGATCC

3

aadA-3’ Xho1

CCGCTCGAGTTATTTGCCGACCTACCT
TGG

4

flaB- 5’ Xho1

CCGCTCGAGCTGTCGCCTCTTGTGGC
TTC

5

BBB22-3’ HindIII

CCCAAGCTTGACTCTTTTTTATGATTTA
TAATTTAGG

6

BBB23-5’ BamHI

CGGGATCCTATTTTCAAACTTTACCTG
ACAGCG
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Primer/Probe

Designation

Sequence (5’-3’)

7

BBB22F (17918) Sall 3’

ACGCGTCGACCCTAAATTATAAATCAT
AAAAAAGAGTC

8

BBB23R (20824) Sall 5’

ACGCGTCGACAATAATTATTAGGCTTT
TAATTCTTTTTAAAGGCC

9

BBB22-Fwd Taqman

AAGAAATTATCGGTGGTATTACCACTTT

10

BBB22-Rev Taqman

CAATTGGCATACCTGTGCTAGATAATA
T

11

BBB23-Fwd Taqman

GCACTAGTTACCGCAACCTGTCT

12

BBB23-Rev Taqman

CTCATTCCAGAAGCCAATGCT

13

BBB22 Probe

AGCATGGCATACATAATAGCTGTTAAT
CCGGC

14

BBB23 Probe

CTAATGGGACTTTATACCAATACGCCT
T
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Figure 6. Generation of the bbb22-23 mutant in B. burgdorferi.
(A) Schematic representation of the wild type (WT), bbb22-23 loci on cp26. The
sequence of the BBB22-23 open reading frame was replaced with a flaBp-aadA
antibiotic resistance cassette. Locations of primers for analysis of the mutant clones are
indicated with small arrows and labels P1-P6. Primer sequences are listed in Table 1.
The boundaries of the deletion construct are indicated by broken lines. (B) PCR
analysis of mutant clones. Genomic DNA isolated from WT and bbb22-23 spirochetes
served as the template DNA for PCR analyses. DNA templates are indicated across
the top of the gel image. The oligonucleotide pairs used to amplify specific DNA
sequences are indicated below the gel image and correspond to target sequences as
shown in A.
The contribution of the bbb22-23 genes to B. burgdorferi mammalian infectivity
was assessed by inoculation of mice with mutant spirochetes lacking bbb22-23 or the
isogenic bbb22-23+ complemented clone at a dose of 1x104 spirochetes. None of the
mice inoculated with the bbb22-23 mutant spirochetes became infected, as assessed
by serology and reisolation of spirochetes from tissues 3 weeks post inoculation (Table
2). Conversely, six out of six mice inoculated with the bbb22-23+ complemented clone
were seropositive and spirochetes were reisolated from tissues (Table 2). To further
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explore the role of these genes in B. burgdorferi murine infection, mice were inoculated
with 1x107 mutant or complemented spirochetes. Strikingly, no mice inoculated with
spirochetes lacking bbb22-23 were infected, even at this high dose, whereas all mice
inoculated with the complemented spirochetes became infected (Table 2). Together
these data demonstrate that bbb22 and/or bbb23 are absolutely required for B.
burgdorferi mouse infectivity by needle inoculation.
Table 2: Genes bbb22 and/or bbb23 are required for B. burgdorferi mouse
infectivity.
Clone

Spirochete dose per mouse

Infected micea

bbb22-23/pBSV2G

1x104

0/6

1x107

0/6

4
bbb22-23/pBSV2G bbb22-23 1x10

6/6

1x107

6/6

a

Number of infected mice/ number of mice analyzed determined 3 weeks post
inoculation by positive serology against B. burgdorferi proteins and reisolation of
spirochetes from ear, bladder and joint tissues.
2.5.3: BBB22 and/or BBB23 are hypoxanthine, adenine and guanine transporters.
Transport and incorporation of hypoxanthine and adenine by wild type B.
burgdorferi have been demonstrated previously [56, 73, 88]. Contrary to the annotated
function of COG2252 domain proteins, none of the biochemically characterized
members of this family has been shown to transport xanthine, uracil or vitamin C.
Instead, they have all been found to function as purine permeases capable of
transporting adenine, hypoxanthine and/or guanine [82, 106-108], supporting the
hypothesis that BBB22 and BBB23 are responsible for transport of purines in B.
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burgdorferi. BBB22-23+ and BBB22-23- spirochetes were examined for transport of
hypoxanthine and adenine using a radioactive filter-binding assay [109]. Transport of
[3H]hypoxanthine was found to be dependent on the BBB22 and/or BBB23 proteins as
the bbb22-23 mutant clone, similar to heat killed wild type spirochetes, was incapable
of hypoxanthine uptake (Fig. 7A). Conversely, wild type and complemented spirochetes
demonstrated increased accumulation of [3H]hypoxanthine over a time period of
approximately 15 minutes (Fig. 7A). Unlike transport of [3H]hypoxanthine, transport of
[3H]adenine was not completely BBB22 and/or BBB23-dependent (Fig. 7B). The
bbb22-23 mutant clone demonstrated transport of [3H]adenine. The [3H]average rate
of adenine uptake for the bbb22-23 mutant spirochetes (0.015 ± 0.006 pmol/107
spirochetes/min) was reduced 68-fold relative to that of wild type and complemented
spirochetes (0.99 ± 0.02 pmol/107 spirochetes/min). A time period of approximately 15
minutes was required for the mutant spirochetes to accumulate a maximum level of
[3H]adenine equivalent to spirochetes harboring functional BBB22-23 proteins. Wild
type and complemented spirochetes achieved maximum [3H]adenine uptake within the
first one minute of the assay (Fig. 7B). The average rate of [3H]adenine uptake by wild
type and complemented spirochetes was 29-fold faster than the average rate of
[3H]hypoxanthine uptake by the same two clones (0.035 ± 0.005 pmol/10 7
spirochetes/min). [3H]Adenine transport by wild type spirochetes was greater than 80%
inhibited in the presence of 200-fold excess of unlabeled adenine (data not shown).
Together these data demonstrate that BBB22 and/or BBB23 are responsible for salvage
of hypoxanthine; whereas, these proteins contribute to uptake of adenine by B.
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burgdorferi but the spirochetes appear to harbor additional transport systems important
for this function.
To further elucidate the function of the BBB22-23 transport system, we took
advantage of the finding that BBB22 and/or BBB23 is the only transporter system for
hypoxanthine uptake. The ability of these proteins to transport other substrates was
determined by measuring [3H]hypoxanthine uptake in the presence of 200-fold excess
unlabeled competitors, including purine derivatives, pyrimidines and ascorbic acid. As
expected unlabeled adenine and hypoxanthine competed for [ 3H]hypoxanthine uptake.
The percent [3H]hypoxanthine uptake in the presence of unlabeled adenine or
hypoxanthine was not statistically difference from that of heat killed or bbb22-23
mutant spirochetes (adenine: P=0.1, P =0.95, respectively; hypoxanthine: P =0.69, P
=0.27, respectively; unpaired t-test) (Fig. 7C). Furthermore, these analyses established
that guanine is an additional substrate for BBB22 and/or BBB23, as the percent
[3H]hypoxanthine uptake in the presence of excess unlabeled guanine was similar to
that of heat killed and bbb22-23 mutant spirochetes (P =0.38, P =0.11, respectively;
unpaired t-test) (Fig. 7C). The presence of xanthine, cytosine, thymine, uracil or
ascorbic acid had no inhibitory effect on [3H]hypoxanthine uptake, indicating that these
metabolites are not transported by BBB22 or BBB23 (Fig. 7C). All in all, these data
clearly establish BBB22 and/or BBB23 function as hypoxanthine-adenine-guanine
permeases.
5’-Methylthioadenosine (MTA) is a sulfur-containing nucleoside produced from Sadenosylmethionine (SAM) during polyamine synthesis in mammalian tissues [110] and
polyamine, autoinducer-1 and biotin synthesis in bacteria [111]. Bacterial 5’35

methylthioadenosine/S-adenosyl homosysteine (MTA/SAH) nucleosidases (Pfs)
catalyze the cleavage of MTA into 5’-methylthioribose (MTR) and adenine [112].
Borrelia burgdorferi harbors three pfs homologues, BB0588 (bgp/pfs-2), BB0375 (pfs-1)
and BBI06 (mtnN). Bgp and Mtn are believed to be present on the surface of the
spirochete, whereas Pfs-1 is predicted to localize to the cytoplasm [111, 112]. Both Bgp
and Pfs-1 have demonstrated MTA nucleosidase activity [112] and together these
proteins are predicted to contribute to adenine salvage from spirochete and host
metabolism [111]. To test the hypothesis that MTA may provide a source of adenine for
salvage by B. burgdorferi, MTA was examined for its ability to compete for
[3H]hypoxanthine transport by BBB22-23. In the presence of MTA [3H]hypoxanthine
transport was significantly reduced relative to transport in the absence of competitor
(P=0.0006; unpaired t-test); however, MTA was not sufficient to reduce
[3H]hypoxanthine transport levels equivalent to that of heat killed or bbb22-23 mutant
spirochetes (P=0.0012, P=0.0030, respectively; unpaired t-test) (Fig. 7C). These data
support the hypothesis that exogenous MTA can serve as a source of adenine for
salvage by B. burgdorferi.
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Figure 7. BBB22 and/or BBB23 are hypoxanthine, adenine and guanine
permeases.
[3H]Hypoxanthine uptake (A) and [3H]adenine uptake (B) by wild type (WT), heat-killed
WT (WT-HK), bbb22-23 mutant (bbb22-23/vector) and bbb22-23 complemented
(bbb22-23/bbb22-23+) spirochetes was measured over a 30 minute time course.
Uptake of radiolabeled purine is expressed in picomoles/107 spirochetes/minute. The
final concentrations of labeled hypoxanthine and adenine in the reactions were 250nM
and 33nM, respectively. The specific activities of labeled hypoxanthine and adenine
were 20 Ci/mmole and 30 Ci/mmole, respectively. Data shown are representative
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results of one of three replicate experiments. (C) [3H]Hypoxanthine (250nM, 20
Ci/mmole) uptake by wild type spirochetes was measured in the absence (no
competitor) or presence of 200-fold excess (50 µM) unlabeled competitor as indicated.
Heat killed wild type (heat killed) and bbb22-23 mutant (bbb22-23) spirochetes in the
absence of competitor served as negative controls. Radioactive uptake was measured
10 minutes after the addition of [3H]Hypoxanthine with or without unlabeled competitor.
Radioactive uptake by wild type spirochetes in the absence of competitor was taken as
100%. All other data are represented as the percent uptake relative to wild type
spirochetes in the absence of competitor. Error bars represent the standard deviation of
triplicate experiments. Statistical analyses were performed using the unpaired t-test
(GraphPad Prism 5.0).
2.6 Discussion
During its infectious cycle B. burgdorferi experiences environments with
potentially distinct purine availability. Hypoxanthine is the most abundant purine in
mammalian blood [113], and it is presumed to be available for salvage by B. burgdorferi
during the blood meal of an infected tick and during the spirochete's transient presence
in the mammalian bloodstream. During mammalian infection B. burgdorferi resides in
various tissues, which have been shown to be rich in adenine [114]. Guanine is present
at low levels in mammalian blood and tissues [113, 114]. It has been demonstrated
previously that B. burgdorferi is able to transport and incorporate adenine, hypoxanthine,
nucleosides and deoxynucleosides into DNA and RNA [56, 73]. However, little to no
transport of guanine or xanthine has been previously observed for B. burgdorferi [73].
We now establish that the homologous proteins BBB22 and/or BBB23, encoded on
cp26, transport hypoxanthine, adenine and guanine and are necessary for B.
burgdorferi mammalian infection. The bbb22 and/or bbb23 gene products were found
to be essential for hypoxanthine uptake. At least one of these transporters is also
important for adenine uptake; however, our data revealed that an additional, as of yet
unknown, protein(s) also contributes to this function. Nonetheless, the function of the
additional adenine transporter(s) was not sufficient to allow full or even attenuated
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survival of bbb22-23 mutant B. burgdorferi in the mouse, as spirochetes lacking only
bbb22-23 were unable to infect mice up to a dose of 1x107 bacteria. These data
suggest that transport of hypoxanthine, rather than adenine, may be critical during the
initial stages of B. burgdorferi mammalian infectivity, consistent with the transient
dissemination of spirochetes through the blood early in infection, while adenine salvage
may be critical for persistent survival of B. burgdorferi in tissues. In addition to direct
scavenge of adenine from host tissues, our data suggest that catabolism of MTA
produced by the host may provide a source of exogenous adenine for purine salvage.
B. burgdorferi harbors two MTA nucleosidase homologs, Bgp and BBI06, which have
been shown or predicted, respectively, to localize to the spirochete’s outer surface,
suggesting that the biological role of these enzymes is to catabolize host derived MTA
[112]. Spirochetes lacking bgp maintain wild type virulence in mice [112], indicating that
BBI06 is able to compensate for the loss of Bgp activity or MTA catabolism contributes
little to B. burgdorferi survival in the mammal. Hypoxanthine transport by BBB22 and/or
BBB23 was competitively inhibited by guanine, demonstrating for the first time that B.
burgdorferi is able to transport guanine and this likely occurs via BBB22 and/or BBB23.
Contrary to annotation of BBB22 and BBB23 as xanthine/uracil/vitamin C permeases,
none of these metabolites were able to compete for hypoxanthine transport.
Furthermore, BBB22 and BBB23 function did not include pyrimidine transport, as
neither cytosine nor thymine competed for hypoxanthine transport. These data are
consistent with the function of the protein members of a new class of nucleobase
transporters containing COG2252 defined by the Aspergillus nidulans hypoxanthineadenine-guanine permease, AzgA [82]. Additional characterized members of this
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subfamily include the E. coli adenine permease, PurP [106, 107] and the two Bacillus
subtilis guanine-hypoxanthine permeases, PbuG and PbuO [108, 115, 116].
Despite the critical roles of BBB22 and/or BBB23 in purine uptake in vivo,
spirochetes lacking bbb22-23 do not exhibit a growth defect in vitro. The rich, complex
B. burgdorferi in vitro growth medium provides excess purines and is likely a source of
nucleosides and deoxynucleosides. In the presence of excess nutrients the unidentified,
additional adenine transporter system may provide a mechanism for the spirochetes to
salvage sufficient amounts of adenine for survival in the absence of BBB22 and BBB23.
We have demonstrated previously that adenine is converted to hypoxanthine by the
adenine deaminase activity of BBK17 (AdeC), which may relieve the requirement for
hypoxanthine salvage in environments high in adenine [57]. B. burgdorferi has been
shown to import and incorporate into DNA and RNA exogenous nucleosides and
deoxynucleosides [56]. Direct salvage of nucleosides and deoxynucleosides by a
transport system other than BBB22 and BBB23 may allow the spirochetes to bypass the
requirement for hypoxanthine, adenine and/or guanine transport to synthesize DNA and
RNA. This mechanism has also been suggested to explain the absence of an in vitro
growth defect for spirochetes lacking the in vivo essential, purine salvage genes guaA
and guaB [43].
The high degree of sequence identity shared between bbb22 and bbb23
suggests that these two genes have evolved as the result of a duplication event.
Moreover, this prediction raises the question of why B. burgdorferi has two purine
permeases encoded by adjacent, paralogous genes on cp26. One possibility is that the
two proteins have distinct substrate specificities. The BBB22 and BBB23 proteins are
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predicted to traverse the spirochete’s inner membrane and therefore the amino acid
sequences of the six periplasmic loops of each protein are likely important determinants
of the substrates that are transported by these purine permeases. Two of the six
putative periplasmic loops within BBB22 (amino acids 207-254 and 418-431,
respectively) and BBB23 (amino acids 219-266 and 430-443) (Fig. 4) are predicted to
be highly divergent between the two proteins, suggesting that these domains may
contribute to differential substrate specificity between the two proteins, if any.
Alternatively, BBB22 and BBB23 may have similar substrate specificities but each
protein functions in response to distinct environmental cues. The sequences and
synteny of the BBB22 and BBB23 homologs appear to be conserved among the Lyme
disease Borrelia sp.. Conversely, the relapsing fever spirochetes appear to only harbor
distantly related BBB23-like sequences (data not shown). Furthermore, the Lyme
disease spirochetes lack the key purine salvage enzymes ribonucleotide reductase,
hypoxanthine-guanine phosphoribosyltransferase (Hpt), adenylosuccinate synthase
(PurA) and adenylosuccinate lyase (PurB) [56, 73, 88] that are present in the relapsing
fever spirochetes [56, 73, 88] and the presence or absence of BBB22 and BBB23
homologs may reflect the distinct purine salvage requirements between the two groups
of pathogens.
The bbb22 and bbb23 transcripts were detected in spirochetes grown in the in
vivo mammalian host environment. Although not statistically significant, the data
suggest that the levels of bbb22 and bbb23 expression in vivo, as determined by
reverse transcription quantitative real time PCR, may be increased relative to the levels
of expression of these genes in nutrient rich in vitro growth conditions. Furthermore,
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these data imply that the expression of the encoded permeases may be upregulated in
response to potentially nutrient limited growth conditions in which purine salvage is
likely critical for B. burgdorferi survival. Key purine salvage enzymes, IMP
dehydrogenase (GuaB) and GMP synthase (GuaA) for the synthesis of GTP and dGTP,
have been shown to be indispensable for B. burgdorferi survival throughout its
infectious cycle [43], suggesting that the tick vector and mammalian host environments
are limited for direct scavenge of GTP and dGTP for RNA and DNA biosynthesis.
Moreover, despite evidence presented herein that guanine can be transported by
BBB22 and/or BBB23, guanine and guanine nucleotide precursors are thought to be
limiting for B. burgdorferi survival in vivo [43, 56]. B. burgdorferi has evolved a unique
purine salvage pathway in the absence of the “classic” purine salvage pathway
enzymes [56, 73, 88], in order to generate dGTP from salvaged hypoxanthine or
hypoxanthine derived from deaminated salvaged adenine [43, 56, 57]. Based on these
data, it is intriguing to speculate that expression of bbb22 and/or bbb23 may be
controlled by the availability of guanine nucleotide precursors leading to increased
hypoxanthine and/or adenine transport when guanine nucleotide pools are low. In
support of this notion, purine nucleotide metabolism in E. coli and B. subtilis has been
shown to be controlled by the availability of purine nucleotides from the environment
[107, 108, 117]. The relative contributions of BBB22 and BBB23 individually to purine
salvage and spirochete survival in vivo, as well as the regulatory mechanism(s)
controlling bbb22 and bbb23 expression, are currently under investigation.
We have demonstrated that BBB22 and BBB23 function in the critical first step of
the purine salvage pathway in B. burgdorferi and in turn, are a gateway into the
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spirochete for the acquisition of essential nutrients. These transporters may also
provide a novel means to deliver potential anti-spirochete molecules. Understanding
the molecular determinants of substrate specificity and regulation of BBB22 and BBB23
may provide the framework for rational design of inhibitors or anti-metabolites targeted
against the B. burgdorferi purine salvage pathway resulting in new treatments for Lyme
disease.
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CHAPTER 3: MOLECULAR DISSECTION OF A BORRELIA BURGDORFERI IN VIVO
ESSENTIAL PURINE TRANSPORT SYSTEM
3.1 Abstract
Borrelia burgdorferi, the causative agent of Lyme disease, lacks the enzymes
required for de novo synthesis of purines for the biosynthesis of RNA and DNA. As a
result, purine salvage from the host environment is critical for the survival of this
pathogen. Previously, our group has shown that genes bbb22 and bbb23, present on
circular plasmid 26 (cp26), encode for purine permeases, which together are important
for the transport of hypoxanthine, adenine and guanine. Additionally, genes bbb22 and
bbb23 together were found to be essential for B. burgdorferi mouse infection. Herein,
our results demonstrate that individually bbb23 and bbb22 each is capable of
transporting hypoxanthine, adenine and guanine. However, BBB23 demonstrates a
lower affinity for hypoxanthine and adenine compared to that of BBB22. Spirochetes
harboring bbb23 alone were non-infectious in mice; whereas spirochetes harboring only
bbb22 were proficient for infection in mice. Although, the spirochete loads in the tissues
from mice infected with spirochetes expressing bbb22 alone were low relative to the
number of spirochetes in the tissues isolated from mice infected with spirochetes
expressing both bbb22 and bbb23. These data suggest that both genes bbb22 and
bbb23 are critical for B. burgdorferi to achieve maximal infection of mice and the
differences in the capabilities of the two transporters may reflect distinct purine salvage
needs that the spirochete encounters throughout its nature infectious cycle.
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3.2 Introduction
Purine nucleobases are required for the synthesis of DNA and RNA.
Consequently, purine biosynthesis and/or transport are critical processes across all
kingdoms of life. Moreover, nucleobase transporters represent possible therapeutic
targets for cancer and infectious diseases [118].
Borrelia burgdorferi , the causative agent of Lyme disease, has a limited genome
and lacks the enzymes required for de novo purine biosynthesis [35, 37, 56, 73, 88].
Therefore, purine salvage from host environments is important for B. burgdorferi
survival and pathogenesis [41, 43, 119]. Recently, our laboratory established that genes
bbb22 and bbb23, on B. burgdorferi essential circular plasmid (cp) 26, together encode
a purine transport system that is required for hypoxanthine transport and contributes to
adenine and guanine transport [119]. Spirochetes lacking both bbb22 and bbb23 are
non-infectious in mice [119]. Conversely, these genes are dispensable for B.
burgdorferi growth in nutrient-rich medium in vitro [119].
The bbb22 and bbb23 genes encode proteins within cluster COG2252 of the
nucleobase cation symporter-2 superfamily (NCS2) [119], which includes permeases
found in bacteria, fungi and plants that are specific for adenine, hypoxanthine and/or
guanine [80, 82, 115, 120-123]. The Aspergillus nidulans AzgA transporter, the founding
member of this family of transporters, has specificity for adenine, hypoxanthine and
guanine [82, 120, 122]. In other species, however, specific purine transport functions
have been attributed to distinct proteins. For example, E. coli harbors two high affinity
adenine permeases, PurP and YicO and two high affinity hypoxanthine-guanine
permeases, YjcD and YgfQ [80, 121]. Similarly, B. subtilis has distinct uptake systems
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for hypoxanthine-guanine and adenine [115, 124]. The Arabidopsis proteins AtAzg1
and AtAzg2 have been shown to be plant adenine-guanine transporters [123] although
hypoxanthine uptake has yet to be examined for these proteins. The B. burgdorferi
BBB22 and BBB23 open reading frames share 79.8% and 78.3% identity at the nucleic
acid and amino acid levels, respectively, and are adjacent genes on cp26, suggesting
that the two genes may be paralogs [119]. While the transport activities conferred by
bbb22 and bbb23 together closely resemble the adenine-hypoxanthine-guanine
permease function of AzgA [82, 119, 122], the individual contributions of bbb22 and
bbb23 to the uptake of specific purines remains unknown. Although the overall amino
acid sequences of the BBB22 and BBB23 proteins are highly conserved, sufficient
sequence divergence may occur within two of the six putative periplasmic loops, which
may allow for differential substrate specificity between the two proteins. In addition, it is
possible that both genes may confer the same transport functions but are differentially
expressed.
Here, we analyzed the individual roles of bbb22 and bbb23 in purine transport
and mammalian infection. Our findings demonstrated that BBB22 and BBB23 were
each capable of hypoxanthine, adenine and guanine uptake, albeit with differing
affinities. Moreover, bbb22, but not bbb23, alone restored murine infectivity to Δbbb2223 spirochetes. Although, the spirochetes carrying bbb22 alone were unable to achieve
the spirochete loads in the infected mouse tissues equivalent to that of bbb22-23+
spirochetes. Together these data suggest that both genes bbb22 and bbb23 are critical
for B. burgdorferi to achieve wild type levels of purine transport and infection of mice.
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3.3 Materials and methods
3.3.1: Bacterial clones and growth conditions.
Escherichia coli strain DH5, were grown in LB broth or LB agar plates at 37ºC.
Gentamicin and spectinomycin were used at 10 µg/ml and 300 μg/ml, respectively. All
B. burgdorferi clones were generated in the low passage B31 A3-68-ΔBBE02-Δbbb2223 clone, which lacks genes bbb22-23 and bbe02 and plasmids cp9 and lp56 [119]. B.
burgdorferi clones were grown in Barbour-Stoenner-Kelly (BSK) II medium at 35ºC.
Gentamicin, streptomycin and kanamycin were used at 40 µg/ml, 50 µg/ml and 200
µg/ml, respectively.
3.3.2: 5’ RACE.
Total RNA was isolated with TRIzol reagent (Life Technologies) from 50 ml
culture of B. burgdorferi clone B31 A3 grown in BSKII to a density of 4x107
spirochetes/ml (log phase) or 5 ml culture at a density 2 x 108 spirochetes/ml (stationary
phase). 5’ Rapid Amplification of cDNA Ends (5’RACE) using the 5’ RACE System for
Rapid Amplification of cDNA Ends, version 2.0 (Life Technologies) was performed
according to the manufacturer’s instructions. 4 µg of RNA was used per reaction and
along with gene specific primers 1297, 1298, and 1299 for bbb22, primers 1316, 1317
and 1318 for the transcript within bbb23 and primers 1300, 1301 and 1302 for bbb23
(Table 3). Nested PCR products were purified using a PCR purification kit (Qiagen) and
the 5’ end of each transcript determined by sequence analysis (Genewiz).
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Table 3. Primers and probes used in this study.

Primer number

Primer name

Sequence (5’-3’)

1006

BBB23 ORF 1392-BamHI-Fwd

CCCGGGGGATCCTTGAAAATATTTTTAAACAATAAAAAGGAAA
GTTT

1007

BBB23 ORF 1356-Fwd-BamHI

CCCGGGGGATCCATGGGTAAGTATGTAAAAGGTTTATTTTTT

1011

BBB23 ORF 1392-Rev-SalI

CCCGGGGTCGACTTACAGATCTTCTTCAGAAATAAGTTTTTGT
TCATAGCC

1123

recA-F

AATAAGGATGAGGATTGGTG

1124

recA-R

GAACCTCAAGTCTAAGAGATG

1137

flaB-Taqman-FWD

TCTTTTCTCTGGTGAGGGAGCT
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Primer number

Primer name

Sequence (5’-3’)

1037

pUC18F

CCCAGTCACGACGTTGTAAAAC

1138

flaB-Taqman-REV

TCCTTCCTGTTGAACACCCTCT

1140

Nid-Taqman-FWD

CACCCAGCTTCGGCTCAGTA

1141

Nid-Taqman-REV

TCCCCAGGCCATCGGT

1166

BBB23 Taqman Fwd

GCACTAGTTACCGCAACCTGTCT

1167

BBB23 Taqman Rev

CTCATTCCAGAAGCCAATGCT

1168

BBB22 Taqman Fwd

GAATCAATCCAAAGAAACATTGTTAT
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Primer number

Primer name

Sequence (5’-3’)

1169

BBB22 Taqman Rev

AGTTGCAGTAACTAATGCGCCAAT

1297

BBB22 GSP-1A (663)

TACTGCGCTTTCTGGAC

1298

BBB22 GSP-1B (388)

AATTTGCAATACTTTCCCTAGC

1299

BBB22 GSP-1D (188)

GCTGATGTTAAGCAAGTTGCAG

1300

BBB23 GSP-1A (700)

CCTGGGCACCTTCTAAAT

1301

BBB23 GSP-1B (424)

AGTTTATAATTTGCTCCCTTACTC

1302

BBB23 GSP-1D (222)

TGCTGTTAGACAGGTTGCG
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Primer number

Primer name

Sequence (5’-3’)

1316

BBB22 IVET RACE GSP1 (1089)

GGCAAAAAAAACTGCAAATAGAAATAATG

1317

BBB22 IVET RACE GSP2 (945)

GCCGTCTACCAGTAATATTTTTTTTGC

1318

BBB22 IVET RACE GSP3 (837)

ATTGAACAAGAGAATAAAAACTATTGATATAAAAGTCC

1525

BBB23-cmyc-HindIII Rev

CCCGGGAAGCTTTTACAGATCTTCTTCAGAAATAAGTTTTTGTT
CATAGCCATAAATAAATTTAATAATAAAAATTAAGC

1526

BBB23 promoter KpnI FW

CCCGGGGGTACCTATTTTCAAACTTTACCTGACAGCG

1527

BBB23 promoter BamHI R

CCCGGGGGATCCTAATAATTATTAGGCTTTTAATTCTTTTTAAA

1528

BBB22 BamHI-Fwd

CGGGATCCTCTCCTGTACTGCTAATATTATGC
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Primer number

Primer name

Sequence (5’-3’)

1529

BBB22 HindIII- Rev

CCCAAGCTTGACTCTTTTTTATGATTTATAATTTAGG

1577

flaBp-fwd-KpnI

CCCGGGGGTACCTGTCTGTCGCCTCTTGTGGCT

1578

flaBp-Rev-BamHI

GGGGGATCCGATTGATAATCATATATCATTCCT

1668

pUC18R

AGCGGATAACAATTTCACACAG

1139

flaB Taqman probe

6-FAM-AAACTGCTCAGGCTGCACCGGTTC-TAMRA

1142

Nid Taqman probe

6-FAM-CGCCTTTCCTGGCTGACTTGGACA-TAMRA

1575

BBB22 Taqman probe

6-FAM-AGCATGGCATACATAATAGCTGTTAATCCGGC-TAMRA
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Primer number

Primer name

Sequence (5’-3’)

1576

BBB23 Taqman probe

6-FAM-CTAATGGGACTTTATACCAATACGCCTT-TAMRA

53

3.3.3: Generation of plasmids containing bbb22 and bbb23.
A region of 107 base pairs sequence upstream of the BBB23 ORF (23p) [119],
and flaB promoter sequence were amplified from B. burgdorferi B31 clone A3 genomic
DNA using Phusion enzyme (Thermo Scientific) and primer pairs 1526 and 1527, and
1577 and 1578 (Table 3), respectively. The B. burgdorferi shuttle vector pBSV2G [125]
and promoter fragments were digested with restriction enzymes KpnI and BamHI,
ligated and cloned in E. coli. Plasmids were confirmed by restriction digestion and DNA
sequence analysis. The annotated BBB23 ORF sequence was amplified from B31 A3
genomic DNA using Phusion enzyme (Thermo Scientific) and primer pair 1006 and
1525. Subsequently PCR using primer pair 1006 and 1011 (Table 3) and the PCR
product derived from primer pair 1006 and 1525 as a template was used to replace the
3’ HindIII restriction site with SalI. The bbb23 gene was ligated into pBSV2G 23p and
pBSV2G flaBp plasmids using restriction enzymes BamHI and SalI and cloned in E. coli.
Plasmids pBSV2G 23p-bbb23 and pBSV2G flaBp-bbb23 were confirmed by restriction
digestion and DNA sequence analysis. DNA fragments containing the BBB22 ORF and
1466 bp of upstream sequence (22distp) or the BBB22 ORF and 160 bp of upstream
sequence (22proxp) were amplified from B31 A3 genomic DNA using Phusion enzyme
(Thermo Scientific) and primer pairs 1007 and 1529 and 1528 and 1529, respectively.
The DNA fragments were ligated into the pBSV2G vector using BamHI and HindIII
restriction sites and the plasmids cloned in E. coli. Plasmids pBSV2G 22distp-bbb22
and pBSV2G 22proxp-bbb22 were confirmed by restriction digestion and DNA sequence
analysis (Genewiz).
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3.3.4: Reintroduction of bbb22 and bbb23 into bbb22-23 mutant spirochetes.
B. burgdorferi clone B31 A3-68-ΔBBE02-Δbbb22-23 was transformed with 20µg
of plasmid pBSV2G 23p-bbb23, pBSV2G flaBp-bbb23, pBSV2G 22proxp-bbb22 or
pBSV2G 22distp-bbb22 and the transformants were selected in semi-solid BSKII 1.5X
medium containing 1.7% agarose and 40 μg/ml gentamicin at 37ºC, 2.5% CO 2 for 6-8
days. B. burgdorferi transformants were confirmed by colony PCR using primers 1037
and 1668. The endogenous plasmid content of each new B. burgdorferi clone was
confirmed by PCR analysis [57] to contain the plasmid content of the B31 A3-68ΔBBE02-Δbbb22-23 parent clone [119].
3.3.5: RNA extraction from in vitro grown cultures.
B. burgdorferi clones bbb22-23+, Δbbb22-23/vector, 23p-bbb23+, flaBp-bbb23+,
22proxp-bbb22+ and 22distp-bbb22+ were grown to a density of 2 x 108 spirochetes/ml in
BSKII medium containing antibiotics. 2 x 108 spirochetes were harvested at 5800 xg for
10 minutes. RNA was isolated using TRIzol reagent (Life Technologies) or Direct-zol
RNA MiniPrep Kit (Epigenetics) and resuspended in 50μl of DEPC-treated dH2O. RNA
samples were DNAse treated using Turbo DNA-free (Life Technologies) and confirmed
to be free of B. burgdorferi genomic DNA contamination by PCR using primers 1123
and 1124. 1μl of SUPERaseIn RNase inhibitor (Life Technologies) was added to
prevent RNA degradation and samples were stored at -80ºC.
3.3.6: Gene expression analysis.
400 ng of B. burgdorferi RNA, extracted from late stationary phase spirochetes,
as described above, was used to synthesize cDNA with the iScript Select cDNA
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synthesis kit (Bio Rad) using random hexamer primers. Reactions lacking reverse
transcriptase were run in tandem as negative controls. Taqman real time quantitative
PCR was performed using 400 ng cDNA, IQ Super Mix (Bio Rad) and primer/probe sets
1168, 1169 and 1575 (bbb22), 1166, 1167 and 1576 (bbb23) and 1137, 1138 and 1139
(flaB), respectively (Table 3). mRNA transcript copies for bbb22 and bbb23 were
normalized with flaB mRNA copies. All the data sets were compared using unpaired ttest using GraphPad Prism 5.0.
3.3.7: Radioactive transport assays.
B. burgdorferi clones were grown to late stationary phase at density of 2x10 8
spirochetes/ml. Radioactive transport assays were performed as previously described
[119]. Briefly, spirochetes were harvested and washed twice in HN buffer (50 mM
Hepes, 50 mM NaCl, pH 7.6) and resuspended in HN buffer to a density of 1x10 9
spirochetes/ml. 5x108 spirochetes were pre-incubated at 37ºC for 30 minutes in 1 ml
reaction volumes containing HN buffer, 3% rabbit serum (Pelfreez) and 6mM glucose.
1.25 µM [3H]hypoxanthine monohydrochloride (specific activity 20 Ci/mmol) (Perkin
Elmer) or 0.25 µM [2,8-3H]adenine (specific activity 30 Ci/mmol) (Perkin Elmer) were
added to the reactions. 5x107 spirochetes were removed at 10 seconds and 15 minutes
following the addition of radioactivity and filtered onto cellulose acetate filter membranes
(Fisher Scientific) using a 10 place filtration manifold (Hoefer, Inc.) pre-loaded with 10
ml of HN buffer and washed again with 10 ml of HN buffer. Filter-bound spirochetes
were collected in scintillation vials containing 3ml of ScintiVerse BD cocktail scintillation
fluid (Fisher Scientific) and radioactivity counted in a Microbeta2 with an efficiency of
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52% (Perkin Elmer). The amounts of hypoxanthine and adenine uptake were converted
to femtomoles/ 5x107 spirochetes as previously described [119].
For B. burgdorferi clones for [3H]hypoxanthine uptake assays in the presence of
cold competitors were grown and prepared as described above. Stock solutions (1 mM)
of each cold competitors hypoxanthine, guanine and adenine and cytosine were
prepared in 25 mM NaOH. All the reactions were carried out in a 1 ml volume containing
1x109 spirochetes, 250 nM [3H]hypoxanthine and either 5 µl of cold competitor (5 μM
final concentration, 20-fold excess) or 5µl of 25 mM NaOH alone . 100 µl aliquots
containing 108 spirochetes were removed 15 minutes following the addition of
radioactivity and collected as described above. The percent [3H]hypoxanthine uptake
for each reaction condition was calculated relative to the amount of [3H]hypoxanthine
transport in the absence of competitor. bbb22-23+ spirochetes heated to 95ºC for 10
minutes (heat killed) served as the negative control for all transport experiments.
3.3.8: Mouse infection experiments.
University of Central Florida is accredited by International Association for
Assessment and Accreditation of Laboratory Animal Care. All the mice experiments
were done according to the guidelines of National Institutes of Health (NIH) and
approved by Institutional Animal Care and Use Committee of UCF. Groups of 6-8 week
old C3H/HeN female mice (Harlan) were inoculated with B. burgdorferi clone bbb22-23+,
Δbbb22-23/vector, 23p-bbb23+, flaBp-bbb23+, 22proxp-bbb22+ or 22distp-bbb22+. Mice
were inoculated intraperitoneally (80%) and subcutaneously (20%) with a total dose of
1x104 spirochetes. Inoculum cultures were analyzed for the endogenous plasmid
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content by PCR, plated on solid BSK medium and individual colonies from each
population analyzed for the presence of virulence plasmids lp25, lp28-1 and lp36 [41].
All inoculum cultures carried the expected endogenous plasmid content (Table 4) and
70-100% of individual colonies from each clone were confirmed to contain all three
virulence plasmids. Blood for serological analysis was collected prior to inoculation and
3 weeks post-inoculation. Mouse infection was determined by serology and spirochete
reisolation from tissues as previously described [119].
3.3.9: Quantitation of spirochete loads in mouse tissues.
Ear, heart and joint tissues were collected for DNA extraction from infected mice.
DNA extraction was performed as previously described [57]. Real time quantitative
PCR was performed using 100 ng DNA from infected mouse tissues. B. burgdorferi
flaB copies and mouse nid copies were quantified using flaB primers/probe and mouse
nid primers/probe, respectively (Table 3) and IQ supermix (Bio Rad), as previously
described [57]. B. burgdorferi flaB copy number was normalized with 1010 nid copies.
Unpaired t-test statistical analysis was performed using GraphPad Prism 5.0.
3.4 Results
3.4.1: The bbb22 and bbb23 genes are separate transcripts.
We previously demonstrated that genes bbb22-23, present on circular plasmid
26 (cp26), encode for purine permeases, which together are essential for B. burgdorferi
mouse infection [119]. However, the individual contributions of bbb22 and bbb23 to
purine transport and mouse infection remains unknown. The annotated BBB22 and
BBB23 open reading frames are separated by a 109 bp intergenic region [37],
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suggesting that these two genes may be transcribed separately and therefore may play
distinct roles in ability of B. burgdorferi to salvage purines. Rapid amplification of cDNA
ends (RACE) was used to identify the 5’ ends of the bbb22 and bbb23 transcripts. The
transcription start site for bbb23 was found to be 260 bps upstream of the annotated
BBB23 open reading frame (ORF), which corresponds to nucleotide 21082 on cp26 and
is 225 bps within the 3’ end of BBB24 (Figure 8). Whereas, the transcription start site for
bbb22 (bbb22prox) was found to be 16 base pairs upstream of the annotated BBB22
ORF at nucleotide 19338 on cp26 (Figure 8). In addition, an in vivo expression
technology (IVET)-based genetic screen performed by our laboratory to identify B.
burgdorferi sequences that are expressed during murine expression [126] identified a
candidate promoter sequence (Bbive103; nucleotides 20322-20238 on cp26) within and
in the same orientation to the BBB23 ORF. Consistent with this finding, 5’ RACE
analysis validated the presence of a transcription start site at nucleotide 20219, 17 bps
downstream of the Bbive103 sequence (bbb22dist) (Figure 8). The double sequence
observed in the sequence analysis of the bbb22dist 5’ RACE PCR product (Figure 8B)
reflects detection of both the transcript derived from the putative distal promoter for
bbb22 as well as the bbb23 transcript itself. Together these data indicate that bbb23
and bbb22 have distinct transcription start sites and that an additional transcription start
site is present 897 bps upstream of bbb22 within bbb23.
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Figure 8. Genes bbb22 and bbb23 each harbor their own promoter.
Rapid Amplification of cDNA Ends (5’ RACE) analysis of the transcription start sites for
the bbb23, bbb22prox and bbb22dist transcripts using RNA extracted from B31 clone
A3 B. burgdorferi. (A) Transcript specific 5’ anchored nested PCR products generated
from the 5’ RACE analysis. Data shown are representative of two replicate experiments.
The DNA ladder is shown in base pairs. (B) DNA sequence chromatographs of the
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DNA sequence of the 5’ RACE products shown in A. Both sequences detected for
bbb22dist are shown. The 5’ nucleotide of each transcript is indicated with a star. (C)
Schematic diagram of the genetic organization of genes bbb22 and bbb23.
Transcription start sites identified in B are shown as bent arrows. The BbIVET in vivo
active promoter sequence within the BBB23 ORF is shown as a light gray box. The
location and numbers of the transcript specific primers used to generate the cDNA for
the 5’ RACE analysis are indicated. A ruler for the nucleotide coordinates on cp26 is
shown.
3.4.2: A long 5’UTR within bbb23 is required for wild type expression of bbb22.
Toward the goal of understanding the individual roles of bbb22 and bbb23 a
panel of plasmids was engineered using the B. burgdorferi shuttle vector pBSV2G [125]
and the BBB23 ORF along with its endogenous promoter sequence (23p-bbb23+), the
BBB23 ORF along with the constitutive flaB promoter, the BBB22 ORF along with the
proximal promoter sequence (22proxp-bbb22+) or the BBB22 ORF along with the
proximal and distal promoter sequences (22distp-bbb22+) (Table 4). In order to
generate spirochetes that only harbored bbb22 or bbb23, the shuttle vector plasmids
carrying bbb23 or bbb22 were each transformed into a low passage B. burgdorferi clone
that lacks both bbb22 and bbb23 [119]. All B. burgdorferi transformants were verified to
contain all of the endogenous plasmid replicons of the Δbbb22-bbb23 mutant parent
(Table 4). The in vitro gene expression of genes bbb22 and/or bbb23 was analyzed in
the B. burgdorferi clones harboring bbb22 alone or bbb23 alone, along with the B.
burgdorferi Δbbb22-bbb23 mutant carrying both bbb22 and bbb23 (bbb22-23+) [119] or
pBSV2G alone (Δbbb22-bbb23/vector) [119] (Table 4) each grown to late stationary
phase, a growth condition we have previously demonstrated to induce purine permease
activity [119] (Figure 9). The expression level of bbb22 under the control of the proximal
promoter alone (22proxp-bbb22+) was significantly reduced compared to that of the level
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of bbb22 expression in the bbb22-23+ positive control spirochetes (P = 0.025) (Figure
9A). Interestingly, however, the level of bbb22 expression in 22distp-bbb22+ spirochetes
was similar to that in bbb22-23+ spirochetes (P = 0.338) (Figure 9A). Together, these
data suggest a possible role for the long 5’ UTR in the 22distp-bbb22+ construct in the
regulation of wild type levels of bbb22. There was no significant difference detected
between the levels of bbb23 transcription in 23p-bbb23+ spirochetes compared to
bbb22-23+ spirochetes (P = 0.113) (Figure 9B), suggesting the upstream sequence
included in this construct was sufficient to drive bbb23 expression to wild type levels. It
was observed that in late stationary phase growth the level of bbb23 expression in
bbb22-23+ spirochetes (Figure 9B) was approximately 100-fold lower than the level of
bbb22 expression in the same clone (Figure 9A). A similar significant difference
between the levels of late stationary phase expression of bbb22 and bbb23 was
detected in wild type spirochetes (data not shown). We found that by driving expression
of bbb23 under the control of the constitutive promoter flaB, the level of bbb23
expression in late stationary phase could be increased to a level similar to that of bbb22
under its endogenous promoter (Figure 9).
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Table 4. B. burgdorferi clones used in this study.
B. burgdorferi

Genotype

Shuttle Vector

Reference

clone
Δbbb22-23/vector B31 A3-68 bbe02::flgBp-kan,

pBSV2G

[119]

B31 A3-68 bbe02::flgBp-kan,

pBSV2G

[119]

bbb22-23::flaBp-aadA, cp9-, lp56-

bbb22-23+

B31 A3-68 bbe02::flgBp-kan,

pBSV2G

bbb22-23::flaBp-aadA, cp9-, lp56-

23p-bbb23+

B31 A3-68 bbe02::flgBp-kan,

pBSV2G

bbb22-23::flaBp-aadA, cp9-, lp56-

flaBp-bbb23+

B31 A3-68 bbe02::flgBp-kan,

pBSV2G

bbb22-23::flaBp-aadA, cp9-, lp56-

22proxp-bbb22+

B31 A3-68 bbe02::flgBp-kan,

pBSV2G

bbb22-23::flaBp-aadA, cp9-, lp56-

22distp-bbb22+

bbb22-23::flaBp-aadA, cp9-, lp56bbb22-23+

23p-bbb23+

flaBp-bbb23+

22proxp-bbb22+

22distp-bbb22+
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This work

This work

This work

This work

Figure 9. In vitro gene expression of bbb22 and bbb23 in B. burgdorferi clones.
RNA was extracted from bbb22-23+, 23p-bbb23 +, flaBp-bbb23+, 22proxp-bbb22+ and
22distp-bbb22+ B. burgdorferi clones at late stationary phase (2x108 spirochetes/ml)
grown at 37°C. Gene expression for bbb22, bbb23, and flaB was quantified by reverse
transcriptase qPCR. (A) bbb22 expression was analyzed for clones bbb22-23+ ,
22proxp-bbb22+ and 22distp-bbb22+. bbb22 mRNA transcripts were normalized to the
flaB mRNA copies. (B) bbb23 expression was analyzed for clones bbb22-23+, 23p64

bbb23+ and flaBp-bbb23+. bbb23 mRNA transcripts were normalized to the flaB mRNA
copies. Data represent the average value of three biological replicates. Error bars
represent the standard deviation from the mean. Statistical analyses were performed
using the unpaired t-test (GraphPad Prism 5.0).
3.4.3: The bbb22 gene allows spirochetes to uptake wild type steady state levels
of hypoxanthine.
We previously demonstrated the combined roles of bbb22 and bbb23 in
hypoxanthine transport [119]. To determine the ability of spirochetes harboring either
bbb22 or bbb23 alone to transport hypoxanthine, uptake assays were performed using
the panel of B. burgdorferi clones carrying either bbb22 or bbb23. The samples were
measured 10 seconds and 15 minutes following the addition of [ 3H]hypoxanthine as a
means to assess the initial rate of transport as well as the ability of the spirochetes to
take up hypoxanthine overtime. The amounts of [3H]hypoxanthine detected in the
spirochetes carrying only bbb22 or bbb23 at the 10 second time point were significantly
reduced compared to that of the bbb22-23+ clone (Figure 10A, P ≤ 0.01), suggesting
that at this initial time point neither gene alone provided B. burgdorferi with the ability to
transport hypoxanthine to the level conferred by both genes together. Interestingly, at
the 15 minute time point spirochetes carrying bbb22 alone driven by the long 5’ UTR
sequence (22distp-bbb22+) achieved a level of hypoxanthine uptake equivalent to that of
spirochetes carrying both genes (Figure 10A, P = 0.96). Whereas, the hypoxanthine
uptake at 15 minutes by spirochetes carrying bbb22 alone under the control of the
proximal promoter (22proxp-bbb22+) was found to be no different than that of the
Δbbb22-23 mutant (Δbbb22-23/vector) (Figure 10A, P = 0.19), further suggesting a role
of the long 5’ UTR sequence in bbb22 function. Similar to what was observed for
22proxp-bbb22+ spirochetes, the bbb23 gene under the control of the bbb23 promoter
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(23p-bbb23+) was not sufficient to provide the Δbbb22-23 mutant with the ability to
transport hypoxanthine (Figure 10A, P = 0.66). Furthermore, although expression of
bbb23 under the control of the constitutive flaB promoter resulted in a significant
increase in hypoxanthine relative to that of the Δbbb22-23 mutant (P = 0.04), the level of
hypoxanthine uptake by flaBp-bbb23+ spirochetes did not achieve that of the bbb22bbb23+ or 22distp-bbb22+ clones (P = 0.01 and P = 0.03, respectively). Together these
data indicated that initial uptake of hypoxanthine was only accomplished by spirochetes
harboring both bbb22 and bbb23, suggesting a synergistic effect of the two genes
together. The bbb22 gene, when expressed under the control of the long 5’ UTR, was
sufficient to attain the level of hypoxanthine uptake of bbb22-bbb23+ spirochetes at the
15 minute time point. Although the bbb23 gene alone conferred modest hypoxanthine
transport function at the 15 minute time point, this fuction was only detectable when
bbb23 was constitutively expressed.
3.4.4: Gene bbb22, but not bbb23, contributes to the ability of B. burgdorferi to
transport adenine.
It has been previously demonstrated that the ability of B. burgdorferi to undergo rapid
transport of adenine is due to genes bbb22-23 [119]. In addition, B. burgdorferi is able
to transport adenine in the absence of bbb22-23, albeit at a much slower rate, likely due
to the function of an additional, as of yet unknown, adenine transporter(s) [119]. To
understand the individual contributions of bbb22 and bbb23 to adenine uptake B.
burgdorferi clones were analyzed 10 seconds and 15 minutes following the addition of
[3H]adenine. Similar to what was observed for hypoxanthine transport at 10 seconds,
clones carrying either bbb23 or bbb22 alone were not able to achieve the level of
66

adenine transport comparable to that of the bbb22-23+ clone (Figure 10B, P < 0.02).
However, unlike clones 23p-bbb23+, flaBp-bbb23+ and 22proxp-bbb22+, clone 22distpbbb22+ demonstrated a significant increase in adenine uptake compared to the bbb2223 mutant clone (Figure 10B, P = 0.003). Furthermore, at the 15 minute time point
there was no statistical difference between the adenine uptake by 22distp-bbb22+
spirochetes and spirochetes harboring both genes (Figure 10B, P = 0.07). Whereas,
the adenine uptake by all other clones was found to be no different than that of the
double mutant at the same time point (Figure 10B, P < 0.5). Together these data
suggest that alone bbb23 does not contribute to adenine transport under the conditions
of this assay. The bbb22 gene when expressed under the control of the long 5’ UTR
was sufficient to restore adenine uptake to the level of bbb22-23+ spirochetes. However,
the initial rate of adenine transport by 22distp-bbb22+ spirochetes was significantly
reduced, suggesting that both bbb22 and bbb23 are required for B. burgdorferi to
achieve a rapid initial rate for adenine uptake.
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Figure 10. The bbb22 and bbb23 alone provide spirochetes with distinct abilities
to uptake purines.
Radioactive purine uptake by B. burgdorferi clones bbb22-23+, Δbbb22-23/vector, 23pbbb23+, flaBp-bbb23+, 22proxp-bbb22+ and 22distp-bbb22+ was measured at 10 seconds
(white bars) and 15 minutes (gray bars) following the addition of (A) 1.25 μM
[3H]hypoxanthine or (B) 0.25 μM [2,8-3H]adenine. Uptake of radiolabeled purine is
expressed in fentomoles/5x107 spirochetes. The specific activity of the labeled
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hypoxanthine used was 20 Ci/mmole. The specific activity of the labeled adenine used
was 30 Ci/mmole. Error bars represent the standard deviation from the mean for at
least two biological replicates. Statistical analyses were performed using the unpaired ttest (GraphPad Prism 5.0).
3.4.5: Adenine and guanine compete with hypoxanthine for uptake by spirochetes
harboring either bbb22 or bbb23 alone.
Taking advantage of the finding that spirochetes harboring bbb22 alone (22distpbbb22+) or bbb23 alone (flaBp-bbb23+) were capable of transporting [3H]hypoxanthine
(Figure 10B), we sought to determine the ability of unlabeled hypoxanthine, adenine
and guanine at 20 fold excess to compete with this function. Consistent with our data
demonstrating that bbb22 is functional to transport adenine as well as hypoxanthine,
[3H]hypoxanthine transport was reduced to nearly 3% and 20% in the presence of
excess cold adenine and cold hypoxanthine, respectively (Figure 11). Furthermore,
bbb22 provided the spirochetes with the ability to transport guanine, as
[3H]hypoxanthine transport by the 22distp-bbb22+ clone was reduced to 37% in the
presence of excess cold guanine. Similarly, flaBp-bbb23+ spirochetes demonstrated a
reduction in [3H]hypoxanthine transport in the presence of excess cold hypoxanthine,
adenine and guanine (13%, 16% and 5%, respectively) (Figure 11). The finding that
that excess cold adenine was able to compete for [3H]hypoxanthine transport by flaBpbbb23+ spirochetes was surprising given that direct transport of [3H]adenine by this
clone was not detected (Figure 10B) and suggested that bbb23 is capable of
transporting adenine only when the substrate is present in high concentrations. As
expected hypoxanthine transport by either of these clones was unaffected by the
presence of the pyrimidine cytosine (Figure 11). Overall these data suggest that
individually both bbb22 and bbb23 are able to provide B. burgdorferi with the ability
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transport to hypoxanthine, adenine and guanine. Moreover, these data suggest a trend
in which adenine is a stronger competitor than guanine for hypoxanthine transport by
bbb22+ spirochetes (P = 0.06) and guanine is a stronger competitor than adenine for
hypoxanthine transport by bbb23+ spirochetes (P = 0.02).

Figure 11. Adenine and guanine compete with hypoxanthine for transport by both
BBB23 and BBB22 individually.
[3H]hypoxanthine (0.25 μM, 20μCi) uptake by 22dists-bbb22+ (white bars) and flaBpbbb23+ (gray bars) spirochetes was determined at 15 minutes following addition of
radiolabeled purine in the absence (no competitor) or presence of 20 fold excess (5 μM)
unlabeled competitor as indicated. [3H]hypoxanthine uptake by 22distp-bbb22+ or flaBpbbb23+ spirochetes in the absence of competitor was taken as 100%. All other data are
represented as the percent uptake relative to 22distp-bbb22+ or flaBp-bbb23+
spirochetes, respectively, in the absence of competitor. Heat killed spirochetes (heat
killed) served as the negative controls.
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3.4.6: bbb22, but not bbb23, is critical for mouse infectivity.
Together genes bbb22 and bbb23 are essential for B. burgdorferi infection in
mice [119]. We have now demonstrated that individually bbb22 and bbb23 vary in their
contributions to the ability of B. burgdorferi transport purines (Figures 3 and 4). To
investigate the individual contributions of bbb22 and bbb23 to mouse infection, mice
were needle inoculated with B. burgdorferi clones bbb22-23+, Δbbb22-23/vector, 23pbbb23+, flaBp-bbb23+, 22proxp-bbb22+, and 22distp-bbb22+ at a dose of 104 or 107
spirochetes. Mouse infection was assessed three weeks post inoculation by serology
and spirochete reisolation from tissues. Of the mice inoculated with B. burgdorferi
clones carrying bbb23 or bbb22 alone, only the mice inoculated with 22distp-bbb22+
spirochetes acquired infections (Table 5). These data suggest that bbb22 is sufficient
for B. burgdorferi infection of mice; whereas, bbb23 is not. In support of this notion,
mice infected with spirochetes harboring bbb23 alone (flaBp-bbb23+ and 23p-bbb23+)
were found to be seronegative and negative for reisolation of spirochetes from tissues
(Table 5). Serology and reisolation of spirochetes from mouse tissues are qualitative
measures of B. burgdorferi infectivity.
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Table 5. Spirochetes carrying bbb22 alone demonstrate qualitative measures of
mouse infectivity.
Clone

Spirochete dose per mouse

Infected micea

bbb22-23+

1x104

6/6

1x107

6/6

1x104

0/6

1x107

0/6

1x104

0/6

1x107

0/6

1x104

6/6

1x107

6/6

bbb22-23+

flaBp-bbb23+

22distp-bbb22+

a

Number of infected mice/ number of mice analyzed determined 3 weeks post
inoculation by positive serology against B. burgdorferi proteins and reisolation of
spirochetes from ear, bladder and joint tissues.
To identify quantitative differences between the B. burgdorferi infections by
22distp-bbb22+ and bbb22-23+ spirochetes the spirochete loads in mouse tissues
inoculated with the two different clones were evaluated by quantitative PCR. The
analysis was also carried out for mouse tissues inoculated with clones flaBp-bbb23+ and
Δbbb22-23/vector, both of which were found to be non-infectious by the qualitative
measures of infection (Table 5). Our results demonstrated that spirochetes loads in ear
and heart tissues infected with the 22distp-bbb22+ clone were significantly reduced
compared to the spirochete burdens in the ear and heart tissues of mice infected with
bbb22-23+ spirochetes (Figure 12A and 12B, P = 0.04 and P = 0.01). Although no
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statistical difference was detected between the spirochete loads in the joint tissues
infected with the two clones, the data suggested a trend toward reduced spirochete
numbers in the joint tissues of mice infected with spirochetes harboring bbb22 alone
(Figure 12C). As expected there was no quantitative detection of spirochetes in the
tissues of mice infected with clones flaBp-bbb23+ and Δbbb22-23/vector. Together
these data suggest that spirochetes harboring bbb22 alone are able to infect mice.
However, the bbb22 gene alone is not sufficient to allow the spirochetes to maintain the
level of B. burgdorferi burden in tissues achieved by spirochetes that carry both the
bbb22 and bbb23 genes together.
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Figure 12. The bbb22 gene alone is not sufficient to maintain wild type levels of
spirochete loads in infected mouse tissues.
DNA was isolated from ear, heart and joint tissues of C3H/HeN mice inoculated with
1x104 bbb22-23+ (●), Δbbb22-23/vector (○), flaBp-bbb23+ (□) or 22distp-bbb22+ (Δ)
spirochetes. Samples were analyzed for spirochete flaB and murine nidogen DNA
copies by qPCR. The data are presented as B. burgdorferi flaB copies per 1010 nidogen
(nid) copies. Each data point represents the average of triplicate measures from the
DNA of an individual mouse. The mean value for each group is indicated by a
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horizontal line. Error bars represent the standard deviation from the mean. Statistical
analysis was performed using the unpaired t-test (GraphPad Prism 5.0).
3.5 Discussion
Borrelia burgdorferi is dependent upon purine salvage from the environment for
the synthesis of DNA and RNA [43, 56, 57, 73, 88]. We have previously shown that
bbb22 and bbb23 present on circular plasmid 26 encode for purine permeases, which
together are essential for B. burgdorferi infection in mice [119]. In this study we now
demonstrate the individual contributions of bbb22 and bbb23 to purine transport and B.
burgdorferi mouse infectivity. To understand the individual roles of bbb22 and bbb23 we
first undertook transcriptional analysis to identify the transcription start sites for both
genes. 5’ RACE analysis identified a distinct transcription start site for bbb22.
Surprisingly however, reverse transcriptase PCR analysis across the intergenic region
between the annotated BBB23 and BBB22 ORFs indicated the presence of a
continuous transcript across the two genes (SJ and MWJ unpublished). Together these
data suggested the possibility of an additional long bbb22 transcript that originates
either from co-transcription with bbb23 or a second bbb22 transcription start site within
the BBB23 ORF. Indeed, the 5’ end of a transcript was identified upstream of bbb22
within bbb23 just downstream of a promoter sequence identified in our BbIVET screen.
The long 5’ UTR sequence produced from the bbb22 distal promoter (22distp) was
found to be important for bbb22 expression as well as bbb22-dependent purine
transport and murine infectivity. A long 5’ UTR was also identified upstream of the
BBB23 ORF. However, the bbb22-23 trans complementation construct carrying only
110 bp of bbb23 upstream sequence was sufficient to restore wild type in vitro purine
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transport and mouse infectivity to Δbbb22-23 spirochetes under the experimental
conditions tested, raising the question as to the importance of the bbb23 5’ UTR (this
work and [119]). Regulation of genes that transport and metabolize purines has been
shown to occur by riboswitch-mediated control [127, 128]. For purine-sensing
riboswitches this type of regulation typically occurs through the binding of guanine or
adenine to the riboswitch sequence in the long 5’ UTR sequences of the regulated
genes [129]. Currently, there are four known classes of purine-sensing riboswitches;
however, additional classes may remain yet undiscovered [129]. While, the extended
leader sequences detected upstream of bbb22 and bbb23 suggests the possibility of a
riboswitch mechanism, bioinformatics analysis of the bbb22 and bbb23 5’ UTR
sequences did not identify one of the four classes of purine-sensing riboswitches. The
functional roles of the 5’ UTR sequences of both the bbb22 and bbb23 genes are
currently under investigation.
Interestingly, the expression level of the bbb23 gene in spirochetes grown to late
stationary phase was found to be approximately 100-fold less than that of the bbb22
gene. This disparity in the level of expression of the two genes in late stationary phase
was eliminated when the bbb23 ORF was expressed under the control of the
constitutive flaB promoter. Standardization of the bbb23 and bbb22 expression levels
allowed direct comparison of in vitro transport function(s) conferred by each gene alone.
The bbb22 gene (22distp-bbb22+) enabled Δbbb22-23 spirochetes to uptake
[3H]hypoxanthine and [3H]adenine. Furthermore, [3H]hypoxanthine uptake by 22distpbbb22+ spirochetes was inhibited by excess cold hypoxanthine and adenine and to a
lesser extend guanine. Whereas, the bbb23 gene (flaBp-bbb23+) enabled Δbbb22-23
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spirochetes to uptake a detectable amount of [3H]hypoxanthine but not [3H]adenine.
Surprisingly, however, [3H]hypoxanthine uptake by flaBp-bbb23+ spirochetes was
inhibited by excess cold hypoxanthine, adenine and guanine. These data suggest that
individually both bbb22 and bbb23 can provide Δbbb22-23 spirochetes with the ability to
transport hypoxanthine, adenine and guanine. However, the transport function
conferred by each gene is quantitatively distinct. Unlike the bbb22 gene, bbb23 was not
sufficient to achieve the level of hypoxanthine uptake afforded by the bbb22-23+
spirochetes at the 15 minute time point. Constitutive expression of bbb23 was required
to determine the transport function conferred by this gene, as the uptake of
hypoxanthine and adenine by 23p-bbb23+ spirochetes was undetectable. Furthermore,
detectable adenine transport by flaBp-bbb23+ spirochetes required a 20 fold higher
concentration of adenine compared to the amount of adenine required for transport by
22distp-bbb22+ spirochetes. Together these findings demonstrate that the purine
transport function encoded by the bbb22 gene alone is greater than the purine transport
function encoded by the bbb23 gene alone. Nonetheless, neither gene alone restored
the initial rate of hypoxanthine or adenine uptake to that achieved by bbb22-23+
spirochetes, demonstrating that both genes are required to provide wild type purine
transport function.
The amino acid sequences of BBB22 and BBB23 are 78.3% identical; however,
the two proteins demonstrate distinct abilities to transport hypoxanthine, adenine and
guanine. This suggests that the differential transport functions of the two proteins may
be dictated by a few keys differences in amino acid residues. Recently, structurefunction analyses of the E. coli adenine-specific permeases PurP and YicO and
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hypoxanthine-guanine-specific permeases YjcD and YgfQ as well as the A. nidulans
adenine-hypoxanthine-guanine permease AzgA identified key amino acid residues
critical for purine uptake activity [80, 122]. Both of these studies identified an aspartic
acid and a glutamic acid residue (Asp339 and Glu394 in AgzA) to be essential for the
transport function for all five COG2252 family members [80, 122]. These residues are
conserved in BBB22 and BBB23. Amino acid Thr275 in YjcD was found to be critical for
hypoxanthine-guanine transport [80, 122]. Interestingly, this residue is conserved in the
other COG2252 proteins [80, 122] including BBB22; however, an isoleucine is present
at this position in BBB23. Furthermore, Gly129 has been shown to be important for
AzgA substrate binding [80, 122]. This residue is conserved in BBB22 and the E. coli
adenine-specific permeases; whereas, BBB23 and the E. coli hypoxathine-guaninespecific permeases have a serine at this position [80, 122]. Future mutational analysis
of the BBB22 and BBB23 proteins, guided by the current understanding of the
molecular interactions important for the transport activities of COG2252 family members,
will provide insight into the molecular basis for the functional differences between these
two highly related transporters.
Of the B. burgdorferi clones carrying only bbb22 or bbb23, only 22distp-bbb22+
spirochetes demonstrated mouse infectivity as measured by serology and reisolation of
spirochetes from infected tissues. This finding, while perhaps expected based on the
near wild type purine transport function of this clone in vitro, highlights the requirement
for the bbb22 5’ UTR sequence for bbb22 function and the distinct individual capabilities
of the bbb22 and bbb23 genes. Hypoxanthine is abundant in mouse blood [113] and
adenine in mouse tissues [114]. B. burgdorferi is transiently present in the blood during
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the initial stages of mammalian infection and then rapidly disseminate to distal tissues
[130-132] Although flaBp-bbb23+ spirochetes demonstrated some ability to transport
purines in vitro, the finding that flaBp-bbb23+ spirochetes are non-infectious in mice
suggests that the purine transport affinity of this clone is not sufficient to support
spirochete survival. While, 22distp-bbb22+ spirochetes demonstrated a higher affinity
for hypoxanthine and adenine uptake compared to flaBp-bbb23+ spirochetes, the initial
rate of purine uptake by 22distp-bbb22+ spirochetes was significantly reduced relative to
spirochetes carrying both genes. Our data suggest that this deficiency resulted in a
quantitative difference in the infectious phenotype of 22distp-bbb22+ versus bbb22-23+
spirochetes. Ear and heart tissues isolated from mice infected with 22distp-bbb22+
spirochetes demonstrated a significantly reduced spirochete load as compared to those
tissues isolated from mice infected with bbb22-23+ spirochetes. A similar trend was
also detected in joint tissues. These data suggest that even though bbb23 is
dispensable for B. burgdorferi survival in mice, this gene is required, in addition to
bbb22, for B. burgdoreri to achieve maximal spirochete loads in infected mouse tissues.
We have established that individually both BBB22 and BBB23 are capable of
transporting hypoxanthine, adenine and guanine. However, the contribution of BBB22
to the purine transport function of B. burgdorferi is greater than that of BBB23. In
addition to the direct involvement of BBB23 in purine transport, the BBB23 ORF
contains regulatory sequence critical for bbb22 expression. The combined critical
nature of the bbb22 and bbb23 genes to B. burgdorferi biology is highlighted by the fact
that these genes are encoded on the essential cp26 plasmid. Cp26, unlike the
approximately 20 linear and circular plasmid of B. burgdorferi is present in all natural
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isolates examined [41], ensuring that the essential bbb22 and bbb23 genes will be
maintained in the B. burgdorferi population. All in all, we conclude that B. burgdorferi
requires both bbb22 and bbb23 for purine transport and mouse infectivity.
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CHAPTER 4: PURINE TRANSPORT CONTRIBUTES TO BORRELIA BURGDORFERI
GROWTH IN IXODES SCAPULARIS TICKS
4.1 Abstract
Borrelia burgdorferi in the tick vector is dependent mainly upon the blood meal to
uptake nutrients. These spirochetes persist through the molt and persist in unfed tick
between feeding. B. burgdorferi has a limited genome and lacks de novo synthesis of
purines. We have previously shown that bbb22 and bbb23 present on circular plasmid
26 encode for hypoxanthine-adenine-guanine permeases. Spirochetes missing both
bbb22-23, do not survive in murine infection by needle inoculation [119]. BBB22 has
high affinity for hypoxanthine and adenine compared to BBB23 (Chapter 3). BBB23 is
not critical for spirochete murine infectivity but it is required along with BBB22 for
maximum infection in the mouse (Figure 12). Here we demonstrate that collectively
bbb22 and bbb23 are not essential for but contribute to spirochete growth in fed Ixodes
scapularis larvae. Spirochetes missing both bbb22 and bbb23 have significantly low
spirochete loads compared to wild type spirochetes in fed larvae. In fed nymphs
spirochetes missing both bbb22 and bbb23 are able to replicate to wild type levels, thus
spirochete replication in fed nymphs is not affected in the absence of both bbb22 and
bbb23. This suggests bbb22-23 mutant spirochete replication to wild type spirochete
levels in fed nymphs might be due to an increased availability of nucleotides and
deoxynucleotides in blood meal compared to fed larvae, which can bypass the
requirement of bbb22 and bbb23 for the salvage of nucleotide precursors. We have also
found that spirochetes harboring BBB23 only are sufficient for spirochete growth in fed
larvae to wild type levels, suggesting that BBB23, a low affinity hypoxanthine-adenine-
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guanine permease, alone is sufficient to transport adequate amounts of purines
required to maintain spirochete loads to wild type levels in fed larvae. Overall our data
suggest that bbb22 and bbb23 contribute to spirochete replication in fed larvae but are
not essential for survival in the tick and BBB23 alone, which is low affinity purine
permease, is sufficient to maintain wild type levels of spirochete loads in ticks. Studying
the requirements for purine transport in B. burgdorferi survival in the tick vector helps in
the understanding of how spirochetes survival varies as a result of the availability of
purine bases, nucleotides and/or deoxynucleotide molecules.
4.2 Introduction
Borrelia burgdorferi, the causative agent of Lyme disease, is maintained in a
complex infectious cycle, involving a tick vector and vertebrate hosts. Lyme disease is
the most commonly reported arthropod borne disease in United States. Ixodes
scapularis (deer tick or black legged tick) and Ixodes pacificus (western-blacklegged
tick) are the major tick vectors responsible for Lyme disease transmission in the United
States [133]. The Ixodes scapularis tick has three distinct developmental stages (larval,
nymphal and adult) in its life cycle. Ticks acquire spirochetes during the larval stage
while feeding on infected hosts [134]. The white-footed mouse (P. leucopus) is the most
common feeding host for larval ticks and an important reservoir for B. burgdorferi [135].
Immature Ixodes scapularis larvae also feed on other small rodents, birds and lizards
[136-138]. After completion of a blood meal, larvae molt into nymphal ticks
(environmental reservoir), which is the life stage mostly responsible for transmission of
spirochetes to humans [22]. Transovarial transmission of spirochetes to newly hatched
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larvae has not been reported [22]. Ixodes scapularis ticks are slow feeders and can feed
up to 5-7 days. Laboratory studies have shown that nymphs rarely transmit spirochetes
on initial attachment to host, but with the majority of transmission occurring between 4872 hours of feeding [139].
Due to limited biosynthetic machinery, B. burgdorferi is dependent upon the host
environment for nutrient uptake [2, 139-142]. In an infected, unfed tick, spirochetes stay
in the lumen midgut and are present in low number. When these ticks feed on a
mammalian host, blood enters the midgut, resulting in change in pH and temperature,
and ultimately leading to exponential spirochete growth [50]. From the midgut, these
spirochetes migrate to salivary glands for transmission to the host [2].
In the tick vector, spirochetes acquire nutrients from the blood meal. B.
burgdorferi lacks de novo synthesis of purines and the spirochete is dependent upon
salvage of purines and other nucleotide precursors from blood meal. B. burgdorferi
genes bbb22 and bbb23 present on circular plasmid 26 encode for purine permeases
[119]. Individually both BBB22 and BBB23 are capable of transporting hypoxanthine,
adenine and guanine (Figure 10, Figure 11). BBB22 has a greater affinity for
hypoxanthine and adenine uptake compared to BBB23. We have also demonstrated
that BBB22 is critical for B. burgdorferi survival in murine infection, but not BBB23
(Table 5). Here we have studied the collective role of bbb22 and bbb23 in spirochete
survival in larval and nymphal ticks. We demonstrate that bbb22 and bbb23 are not
essential for spirochete survival in the tick vector, but affect the spirochete load in the
midgut, suggesting the role of the genes purine salvage from the blood meal.
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Furthermore, addition of bbb23 alone to bbb22-23 mutant spirochetes was sufficient to
restore wild type level of spirochete loads in fed larvae.
4.3 Materials and methods
4.3.1: B. burgdorferi clones and growth conditions.
B. burgdorferi clones, ∆bbb22-23/vector, bbb22-23+ and flaBp-bbb23+ made
previously by our lab were used in these tick studies ([119], Chapter 3). ∆bbb2223/vector spirochetes are missing bbb22-23 from cp26, bbb22-23+ spirochetes are
trans-complements for bbb22-23 and flaBp-bbb23+ spirochetes are trans-complements
for bbb23 in bbb22-23 mutant background spirochetes. B. burgdorferi cultures were
grown in BSKII medium at 35ºC. BSK1.5X medium and 1.7% agarose were used as
plating media. Gentamicin was used at a concentration of 40 µg/ml.
4.3.2: Mouse infection experiments.
University of Central Florida is accredited by International Association for
Assessment and Accreditation of Laboratory Animal Care. All the mice experiments
were conducted according to the guidelines of National Institutes of Health (NIH) and
approved by Institutional Animal Care and Use Committee of UCF. 6-8 week old
C3H/HeN female mice were anesthetized with 2.5% isoflurane. 100-200 μl of preinoculation blood was collected by retro-orbital bleeding for serology studies. Mice were
inoculated intraperitoneally (80%) and subcutaneously (20%) with a total dose of 1x10 4
B31 clone A3 B. burgdorferi in a total 250μl BSKII medium. Blood was re-collected 21
days post inoculation. Mouse infection was determined by serology and the results were
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further confirmed by spirochete reisolation from infected mouse tissues as described
previously [119].
4.3.3: Feeding uninfected larvae on mice.
Newly hatched naive Ixodes scapularis larvae were received from Dr. Michael
Levin at the Centers for Disease Control through the BEI Resources/National Institute
for Allergy and Infectious Diseases repository and were maintained under ~98%
humidity a bell jar containing using a saturated solution of potassium sulfate. 4-5 month
old larvae were used for mouse feeding. Larvae were dehydrated in a bell jar containing
saturated solution of ammonium sulfate (relative humidity ~81%) for 48 hours prior to
feeding on mice. Two B. burgdorferi infected mice (see above) were anesthetized by
intraperitoneal injection of an 80 µl mixture of ketamine and xylazine (ketamine 25mg/ml, xylazine - 7.6mg/ml). 100-150 larvae were placed onto a shaved area on the
back of each mouse. Once mice recovered from anesthesia they were put individually
into perforated plastic tubes covered with a piece of cloth and both the ends were
closed with rubber stoppers. Mice were able to turn around in the tube but were not able
to scratch their backs. These tubes were kept in cages for 4 hours to give sufficient time
for larvae to attach to mouse skin. After 4 hours mice were removed from tubes and
were transferred to the wire bottom feeding cages sitting over a pan of water. Fed
larvae were collected from water every day for 7 days. Once all the larvae were
collected, mice were transferred to regular cages.
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4.3.4: RNA isolation from infected ticks.
Collected fed larvae (see above) were transferred to saturated potassium sulfate
chambers. After 4 weeks, these larvae were molted into nymphs. Two groups having 20
unfed nymphs in each group were homogenized with a small pestle in BSKII media.
Homogenized ticks were spun at 5800G for 10 minutes. Pellets were dissolved in 1 ml
of TRIzol reagent (Life Invitrogen). TRIzol mix was transferred to Phase Lock Gel Heavy
tubes (5 Prime) and was incubated for 10 minutes at room temperature. 300 µl
chloroform was added to TRIzol mix and tubes were shaked vigorously for 15 seconds.
Tubes were spun at 13000 G for 5 minutes at room temperature. Top layers of RNA
were transferred to another tubes and RNA samples were precipitated using 500 µl
isopropanol. Samples were spun at 15300 G at 4ºC for 10 minutes. RNA pellet was
washed twice with 200 µl of 70% ethanol. RNA pellet was dissolved in 100 μl DEPC
water. RNA samples were treated with TURBO DNase (Life Technologies) as described
previously ([119], Chapter 3). RNA samples were treated with a total of 1 ul Riboguard
RNase inhibitor 40 U/ µl (Epicenter).
4.3.5: RNA isolation from in vitro grown B. burgdorferi cultures.
B31 A3-68-ΔBBE02 Wild type spirochetes was grown to a density of 4 x 10 7
spirochetes/ml in BSKII media at 37ºC. 107 spirochetes were spun at 5800G for 10
minutes. BSKII media was removed and RNA was isolated from spirochete pellet using
1 ml of TRIzol reagent (Life Technologies) as described above. RNA pellet was
dissolved in 100 μl of DEPC treated water. 1ul of RNase inhibitor was added to prevent
RNA degradation by RNase. RNA sample was treated with TURBO DNase (Life
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Technologies) as described previously ([119] Chapter 3). 1ul of RiboGuard RNase
inhibitor (Epicenter) was added to prevent RNA degradation.
4.3.6: Gene expression by real time quantitative PCR.
400-600 ng of RNA was used to make cDNA using qScript cDNA Supermix
(Quanta Biosciences) as per manufacturer’s guidelines. Reactions missing reverse
transcriptase were run as control. 2000 ng of cDNA was taken for each Real Time
Quantitative PCR reaction. Expression of B. burgdorferi genes bbb22 and bbb23 was
determined using primer-probe sets 1-2-5 and 3-4-6 respectively (Table 6). bbb22 or
bbb23 transcript copy number was normalized with B. burgdorferi flaB mRNA copy
number. RNA from in vitro grown B. burgdorferi clone A3 was taken for comparison.
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Table 6. Primers and probes used in this study.
Primer

Primer name

Primer sequence

1137

flaB-Taqman-FWD

TCTTTTCTCTGGTGAGGGAGCT

1138

flaB-Taqman-REV

TCCTTCCTGTTGAACACCCTCT

1166

BBB23 Fwd - Taqman

GCACTAGTTACCGCAACCTGTCT

1167

BBB23 Rev - Taqman

CTCATTCCAGAAGCCAATGCT

1168

BBB22 Fwd - Taqman

AAGAAATTATCGGTGGTATTACCACTTT

1169

BBB22 Rev - Taqman

CAATTGGCATACCTGTGCTAGATAATAT

1575

BBB22 Taqman probe

6-FAM-

number

AGCATGGCATACATAATAGCTGTTAATCCGGCTAMRA
1576

BBB23 Taqman probe

6-FAM-CTAATGGGACTTTATACCAATACGCCTTTAMRA

1139

flaB Taqman probe

6-FAM-AAACTGCTCAGGCTGCACCGGTTCTAMRA

4.3.7: Feeding artificially infected larvae on mice.
4-5 month old larvae were kept in saturated ammonium sulfate container for
dehydration for 24-48 hours. After dehydration larvae were immersed in 20 ml of B.
burgdorferi clone bbb22-23+, Δbbb22-23 or flaBp-bbb23+, at a density of 2x107
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spirochetes/ml. B. burgdorferi clones were tested for the presence of virulence plasmids
lp25, lp28-1 and lp36. More than 70% of the populations for all B. burgdorferi clones
were positive for these virulence plasmids. Larvae were co-incubated in the B.
burgdorferi cultures for 50 minutes at 37ºC and samples were inverted every 10 minutes.
After 50 minutes tubes were centrifuged at low speed and the B. burgdorferi cultures
were removed. Larvae were washed twice with cold 1X phosphate buffered saline
(PBS) buffer. Tubes containing larvae were dried using filter paper and tubes were
returned to potassium sulfate container. Artificially infected larvae were allowed to
recover for two days prior to feeding on mice. At least 3 uninfected 6-8 week old female
C3H/HeN mice per group were fed upon by artificially infected larvae as described
above and fed larvae were collected for 7 days. Fed larvae were transferred to the
saturated potassium sulfate container and a portion of each population was reserved to
molt into nymphs. Following the molt B. burgdorferi nymphs were allowed to feed on at
least 3 uninfected mice per group at a dose of 25 nymphs/mouse. Blood was collected
from all mice before tick feeding and 21 days after start of tick feeding.
4.3.8: Determination of spirochete loads in ticks.
Individual unfed larvae, fed larvae, unfed nymphs and fed nymphs were surface
sterilized in 1 ml of 3% H2O2 for 5-10 minutes followed by 1 ml of 70% ethanol for 5-10
minutes. Ticks were air dried and individual ticks were homogenized using a pestle in
BSKII medium containing 40ug/ml gentamicin. BSK plating medium was prepared to
contain the 100 X B. burgdorferi antibiotic cocktail including 2mg/ml phosphomycin,
5mg/ml rifampicin and 250 µg/ml amphotericin. Spirochete loads per tick were
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determined by plating each tick homogenate and quantifying the number of colony
forming units.
4.4 Results
4.4.1: B. burgdorferi express bbb22 and bbb23 in the tick vector.
The B. burgdorferi genes bbb22 and bbb23 present on circular plasmid 26 are
expressed both in vitro and during a murine infection [119]. To determine whether
bbb22 and bbb23 are expressed in unfed nymphal ticks, uninfected larvae were fed
upon on mice infected with B. burgdorferi clone A3. Fed larvae were collected and were
kept in a container having saturated solution of K2SO4 until they molted into nymphs.
cDNA was made using RNA extracted from unfed infected nymphal ticks. Real time
quantitative PCR was performed to determine bbb22 and bbb23 expression in the tick
vector. Here we show that spirochetes express both bbb22 and bbb23 in unfed nymphs
and that bbb22 expression is 3.7 fold higher than bbb23 (P = 0.0086) (Figure 14) In vitro
grown B. burgdorferi did not show a significant gene expression difference in between
bbb22 and bbb23.

90

Figure 13. B. burgdorferi express bbb22 and bbb23 in unfed Ixodes scapularis
nymphs.
Total RNA was isolated from in vitro grown B31 A3 spirochetes at a density of 4 x 107
spirochetes/ml. B. burgdorferi grown in BSKII media with pH 7.5 at 35°C. Total RNA
from unfed nymphs infected with B31 A3 spirochetes, was isolated from a group of 20
unfed nymphs. Expression of bbb22 and bbb23 was determined by Real Time
Quantitative PCR. bbb22 and bbb23 gene transcript copies were normalized to flaB
transcript copied. In vitro and unfed nymph data represents an average of two biological
replicates. Error bars represent mean standard deviation. Statistical analysis was done
using unpaired t-test (Graph Pad Prism 5.0).
4.4.2: bbb22 and bbb23 are not essential for B. burgdorferi survival in the tick but
play an important role in B. burgdorferi growth in fed larvae.
B. burgdorferi genes bbb22 and bbb23, encode for purine permeases [119].
BBB22 and BBB23 are both hypoxanthine-adenine-guanine permeases (Chapter 3) and
together are required for B. burgdorferi mouse infection [119]. To determine if bbb22
and bbb23 together have a role in spirochete survival or growth in Ixodes scapularis
naïve larvae were artificially infected with B. burgdorferi clones Δbbb22-23/vector or
bbb22-23+ and the spirochete loads in the tick analyzed throughout the tick-mouse
infectious cycle (Figure 14). Individual unfed and fed ticks (larvae and nymphs) were
91

homogenized and were plated for assessment of the number of spirochete colony
forming units per tick. These data demonstrated that spirochetes lacking both bbb22
and bbb23 are able to survive throughout larval and nymphal tick stages, suggesting
bbb22 and bbb23 are not essential for spirochete survival in Ixodes scapularis (Figure
15A). The number of spirochetes per unfed larva were the same for both the bbb22-23
mutant and bbb22-23+ spirochetes, indicating artificial infection of the unfed larvae
resulted in equal infection with both clones.

Interestingly, the number of bbb22-23

mutant spirochetes in the fed larvae was significant reduced compared to that of the
bbb22-23+ spirochetes (Figure 15A). Spirochete loads in fed larvae infected with bbb2223+ spirochetes were same as fed larvae infected with wild type spirochetes indicating
that the bbb22-23+ clone retains the wild type phenotype (data not shown Fed larvae
were molted into nymphs and these nymphs were fed upon uninfected mice.
Surprisingly, there was no difference in spirochete loads in fed nymphs between bbb2223 mutant spirochetes and bbb22-23+ spirochetes (Figure 15B).
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Figure 14. Experimental design of tick-mouse transmission of B. burgdorferi.
Ixodes scapularis unfed larvae were immersed in B. burgdorferi cultures of Δbbb2223/vector or bbb22-23+ spirochetes grown at a density of 2 x107 spirochetes/ml. Tubes
were incubated at 35°C for 45 minutes. 100-150 artificially infected larvae were fed on
each mouse. Fed larvae were collected for 5-6 days. To determine mouse infection,
serology studies and spirochete reisolation experiments were performed on mice fed on
by uninfected larvae after 3 weeks. Some of the individual fed larvae were plated in
BSK plating media to count the spirochetes loads. Larvae were molted into nymphs and
nymphs were fed on uninfected mouse. Infection in mice fed upon by nymphs and
spirochete load in individual nymphs were determined as described for larvae [43].
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Figure 15. bbb22-23 play critical role in B. burgdorferi growth in fed larvae.
Unfed larvae were artificially infected with bbb22-23+ or Δbbb22-23/vector spirochetes
by immersing these larvae in B. burgdorferi cultures at a density of 2x107 spirochetes/ml.
100-150 artificially infected larvae for each clone were fed on uninfected mice with 4
mice each B. burgdorferi clone. (A) Seven days following larval feeding, the number of
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spirochetes per unfed and fed larva were determined by plating on solid of
homogenized ticks on solid medium. (B) Following the molt, nymphal ticks were fed on
mice and the number of spirochetes per unfed and fed nymph were determined as
described. The data represents the average of at least 5 individual unfed larvae, 25 fed
larvae, 25 unfed nymphs and 20 fed nymphs. Error bars represent standard deviation
from mean.
4.4.3: bbb22-23 are required by B. burgdorferi in tick to mouse transition.
Previous data from our group has shown that bbb22-23 are essential for mouse
infection by needle inoculation. Here we found that bbb22-23 are not essential for
spirochetes survival in tick vector. To study if bbb22-23 mutant spirochetes persist in
mice on tick transmission, serology studies and spirochete reisolation experiments were
done on mice fed upon by infected unfed larvae. Unfed larvae and nymphs infected
with bbb22-23 mutant or bbb22-23+ spirochetes were fed on mice. The mice fed upon
by larvae infected with bbb22-23 mutant spirochetes did not show immune response.
Results were confirmed by spirochete reisolation experiment from mouse tissues. Mice
fed upon by bbb22-23+ spirochetes showed immune response and showed spirochete
growth from mouse tissues (Table 7). Serology studies showed no immune response in
mice fed upon with unfed larvae or unfed nymphs infected with bbb22-23 mutant
spirochetes (Table 7). So, bbb22-23 are also essential for mouse infection by tick
transmission.
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Table 7: Spirochetes lacking bbb22-23 are non-infectious in mice by tick bite
transmission.

number of infected mice/totala

Ticks

Clone

Larvae

Δbbb22-23/vector

0/4

bbb22-23+

2/2

Δbbb22-23/vector

0/4

bbb22-23+

3/3

Nymphs

a

Data is from two separate tick experiments. Infection was assessed by immunoblot
analysis with B. burgdorferi lysate at 3 weeks post tick feeding and by spirochete
reisolation from mouse ear, bladder and joint tissues collected from mice inoculated with
B. burgdorferi clones.
4.4.4: The bbb23 gene is sufficient to restore bbb22-23+ spirochete loads in fed
larvae.
We have previously shown that BBB23 is a low affinity purine permease (Chapter
3). Constitutive expression of the bbb23 gene (flaBp-bbb23+) allowed hypoxanthine
uptake by Δbbb22-23 mutant spirochetes (Chapter 3). Because hypoxanthine may be
the predominate purine available to B. burgdorferi for salvage from the tick blood meal
this suggested that constitutive expression of bbb23 may be sufficient to restore wild
type spirochete loads to Δbbb22-23 mutant spirochetes in fed larvae. Naïve larvae
were artificially infected with B. burgdorferi clone Δbbb22-23, flaBp-bbb23+ or bbb22-23+
and the infected ticks allowed to feed on mice, as previously describe. Spirochetes
loads ticks were quantified. The data indicates that spirochetes harboring bbb23 alone
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are able to replicate to numbers equivalent to that of bbb22-23+ spirochetes in fed
larvae (Figure 16).

Figure 16. bbb23 alone is sufficient to maintain spirochete loads to wild type
levels in fed larvae.
Unfed larvae were artificially infected with bbb22-23+, Δbbb22-23/vector and flaBpbbb23+ as discussed above (Figure 15A). Infected larvae were fed on mice and fed
larvae were collected and spirochete loads were calculated in individual larval tick as
discussed above (Figure 15A).
4.5 Discussion
Borrelia burgdorferi is dependent upon purine salvage to synthesize its DNA and
RNA. Previously we showed bbb22 and bbb23 are purine transporter genes present on
circular plasmid 26 and are essential for survival of spirochetes in the mouse [119]. B.
burgdorferi gene expression changes with environmental conditions such as
temperature, pH, mammalian host, tick vector and availability of nutrients to allow B.
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burgdorferi to survive in unique environmental niches [143]. Some of the well-studied
genes in B. burgdorferi such as ospA and ospC show differential gene expression in the
tick vector and the murine host. OspA and OspC are outer surface proteins in B.
burgdorferi which these spirochetes express in tick vector and mammalian host,
respectively [54]. Gene expression of ospC goes down in ticks whereas ospA
expression goes down in mammalian host. So, as B. burgdorferi demonstrates changes
in gene expression with changes in growth conditions, we were interested to determine
the level of bbb22 and bbb23 gene expression in the tick vector. We have shown
previously that bbb22 and bbb23 are expressed both in vitro and during mouse infection.
To further study the role that spirochete purine salvage plays in tick vector, we first
demonstrated that both these genes are expressed in unfed nymphal Ixodes scapularis,
suggesting that these genes may contribute to B. burgdoreri persistence in the tick.
B. burgdorferi has also been shown to transport nucleotides and
deoxynucleotides such as CMP, dCMP, AMP, dAMP, GMP and dGMP [56]. Nucleotides
and deoxynucleotides are taken up by B. burgdorferi and are utilized directly to
synthesize DNA and RNA [56]. Availability of sufficient amounts of nucleotides and
deoxynucleotides in an external environment may bypass the requirement of both
bbb22 and bbb23, as purine salvage may not be critical under these growth conditions.
Indeed, Δbbb22-23 mutant spirochetes grow normal in BSKII medium, which is a
complex, nutrient rich growth environment [119]. The inability of Δbbb22-23 mutant
spirochetes to survive in the mouse suggests that the in vivo environments in the
mammalian host contain insufficient levels of nucleotides and deoxynucleotides
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spirochete survival in the absence of purine salvage. To study the role that bbb22 and
bbb23 play in spirochete survival in the tick vector, spirochete survival and replication
was examined in the tick developmental stages throughout the B. burgdorferi infectious
cycle. The data demonstrated that genes bbb22 and bbb23 are not required for B.
burgdorferi survival in larval and nymphal ticks, but contribute to the spirochete growth
in larval ticks. The survival of bbb22-23 mutant spirochetes in tick vectors might be due
to the availability of nucleotides and/or deoxynucleotides during a blood meal, which
can bypass the requirement for salvage of purine nucleobases. As the tick blood meal
may only provide finite amounts of nucleotides and/or deoxynucleotides that can be
utilized by spirochetes, having the ability to salvage purines through purine transporters
may promote spirochete replication. Because of the difference in body size between
larvae and nymphs, the size of the larval blood meal may be smaller than that of
nymphs perhaps resulting in reduced amounts of available nucleotides and
deoxynucleotides. This suggests that the advantage of purine transporters for
spirochete replication may be more critical in larvae compared to nymphs. This
reasoning may provide an explanation for why bbb22-23 mutant spirochetes have low
spirochetes load in larval ticks but not in nymphal ticks compared to the wild type
spirochetes. Furthermore, the addition of bbb23 to bbb22-23 mutant spirochetes allows
purine scavenging in fed larvae, restoring the spirochetes ability to replicate to levels
similar to that of wild type spirochetes. To date no defined, minimal medium is available
for B. burgdorferi growth in vitro. The use of minimal medium would allow experimental
determination of concentrations of purines and other nucleotide precursors needed for
spirochete survival and how bbb22 and bbb23 expression and function changes based
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upon the availability of different amounts of purines. Future studies are focused on
studying the role of BBB22 purine transporter in the growth of spirochetes harboring
bbb22 alone in larval ticks.
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CHAPTER 5: CONCLUSIONS AND FUTURE STUDIES
5.1 Conclusions
B. burgdorferi has a unique infectious cycle that includes a variety of vertebrate
hosts and a tick vector. Even though these spirochetes are not known to produce toxins
[37, 39], they are still capable of invading the host tissues, potentially causing a disease
state for months to years. These spirochetes cause disease by triggering the body’s
immune response, and resulting in the activation of various inflammatory reactions [144].
B. burgdorferi experiences various environmental changes during its infection cycle
[145], therefore it is important to understand the molecular mechanisms involved in the
survival of B. burgdorferi throughout its infectious cycle. B. burgdorferi shows changes
in its gene expression in response to the different the environments it encounters such
as the tick vector, mammalian host as well as distinct in vitro growth conditions [145].
Identifying and functionally characterizing the genes essential for B. burgdorferi survival
in vivo can be helpful in identifying new therapeutic targets to treat Lyme disease.
Due to the reduced genome and limited metabolic capabilities, these spirochetes
cannot survive in nature without a host, and require a complex, high nutrient medium for
in vitro growth. B. burgdorferi lacks genes required for the synthesis of amino acids,
fatty acids and nucleotides [146]. As nucleotides and deoxynucleotides are required for
the synthesis of RNA and DNA, respectively, B. burgdorferi possess a purine salvage
pathway for obtaining the nucleotide and deoxynucleotide precursors in place of de
novo synthesis. Identifying the genes involved in the purine salvage pathway and
understanding their importance in the infectious cycle of B. burgdorferi, will help in
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better understanding the molecular mechanisms involved in Lyme disease
pathogenesis.
Genes bbb22 and bbb23, present on cp26, are annotated to encode for xanthineuracil permeases and belong to the nucleobase cation symporter 2 (NCS2) superfamily.
bbb22 and bbb23 are 79.8% and 78.3% identical at the nucleotide and amino acid
levels, respectively. Both BBB22 and BBB23 appear to possess 12 transmembrane
domains. The successful deletion of both bbb22 and bbb23 together showed that both
of these genes are not essential for the survival of B. burgdorferi in vitro (Chapter 2)
[119]. The in vitro purine transport assay results show that spirochetes require bbb22-23
for hypoxanthine uptake (Chapter 2, Figure 7A) [119]. No hypoxanthine uptake by the
bbb22-23 mutant spirochetes suggests that there is no additional high affinity
hypoxanthine transporter in B. burgdorferi. The data from a similar experiment with the
use of [3H]adenine in place of [3H]hypoxanthine showed that BBB22-23 contribute to,
but are not essential for, adenine uptake; as even in the absence of bbb22-23,
spirochetes showed slow uptake of adenine (Chapter 2, Figure 7B) [119]. The
competition assays were also performed to see if these transporters also transport
xanthine, uracil (as annotated function) and pyrimidines. The competition assays were
performed using 200 fold higher concentration of the various unlabeled competitors
compared to [3H]hypoxanthine to identify the substrates being transported by BBB22-23.
Data suggests that only the unlabeled hypoxanthine, adenine and guanine among
various purines and pyrimidines, compete with [3H]hypoxanthine for their uptake by
BBB22-23. This suggests that the BBB22-23 do not actually operate their annotated
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function as a xanthine/uracil permease, but rather are purine permeases for
hypoxanthine, adenine and guanine transport (Chapter 2) [119].
The BBB22-23 transport system belongs to COG2252 cluster and shows a
similar function to the AzgA purine transporter in Aspergillus nidulans. AzgA specifically
transports hypoxanthine, adenine and guanine [82]. To understand the importance of
BBB22-23 in B. burgdorferi-mouse infection, the mice were inoculated with spirochetes
missing bbb22-23. Data from a mouse needle inoculation experiments demonstrated
that spirochetes missing bbb22-23 did not survive in the mouse, suggesting that the
purine permease activities of BBB22-23 are essential for B. burgdorferi survival in the
mammalian host (Chapter 2, Table 2) [119]. The purine permease activities of BBB2223 are not essential for the in vitro survival of B. burgdorferi. B. burgdorferi has
previously shown to uptake of nucleosides and deoxynucleosides that are directly used
in the synthesis of RNA and DNA [56]. The spirochetes missing bbb22-23 can grow
normal in vitro because the BSK II medium is highly rich in nutrients, and the availability
of the nucleotides and deoxynucleotides might be sufficient to bypass the requirement
for bbb22 and bbb23 (Chapter 2, Figure X) [119]. This is in contrast to the environment
in mice, where the availability of the nucleotides, deoxynucleotides and adenine to B.
burgdorferi is not sufficient for its survival. These spirochetes therefore have to rely
upon purine salvage to survive in the mouse but not in BSKII medium in vitro. bbb22-23
mutant spirochetes do not transport hypoxanthine, but still do transport adenine at a
very slow transport rate compared to the wild type. After uptake, the adenine is
converted into hypoxanthine by adenine deaminase [43]. However, this slow adenine
uptake by bbb22-23 mutant spirochetes is not sufficient for spirochete survival in a
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mouse, suggesting that bbb22-23 mutant spirochetes might require high amounts of
adenine at the initial stages of mouse infection to compensate for the lack of
hypoxanthine uptake for their survival.
B. burgdorferi quickly start disseminating from the inoculation site into the mouse
tissues via the blood stream [147]. Adenine is known to be abundant in the mouse
tissues and hypoxanthine in the blood [114]. During the initial stages of infection, the
spirochetes are found in blood stream for a very short period where hypoxanthine is
abundant. Because the bbb22-23 mutant spirochetes are not able to uptake
hypoxanthine, these spirochetes likely die in the early stages of mouse infection. Indeed,
all the mice inoculated with the different doses of bbb22-23 mutant spirochetes were
seronegative (Chapter 2, Table 2), further suggesting that bbb22-23 mutant spirochetes
were cleared from the mice in the early stages of infection and before the immune
response started. In conclusion, the in vivo phenotype of the bbb22-23 mutant
spirochetes highlights the importance of purine salvage for the ability of B. burgdorferi to
survive in the mammalian host.
These results led us to further investigate the individual roles of the bbb22 and
bbb23 genes. A few questions we wanted to answer were: 1) Are the BBB22 and
BBB23 both purine transporters? 2) Do BBB22 and BBB23 each have distinct substrate
specificities for the dfferent purines? 3) Does one of the two purine transporters have a
great affinity for purine uptake compared to the other? 4) Does B. burgdorferi require
both the bbb22 and bbb23 for mouse infection? To answer all of these questions, we
made B. burgdorferi clones, in which only one of the purine permease encoding genes
(bbb22 or bbb23) was expressed in the spirochetes. To dissect the BBB22-23 purine
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transport system, it was important to identify the transcription start sites for bbb22 and
bbb23. Our results demonstrate that bbb22 and bbb23 are separate transcripts and that
the transcription start sites for bbb22 and bbb23 are located at 16 and 260 base pairs
upstream of their respective open reading frames, respectively. (Chapter 3, Figure 8).
Previously, our group found an in vivo active promoter sequence within the BBB23 ORF
sequence. Initially, we speculated that this sequence may function as a promoter
sequence for the bbb22 transcript. Our 5’ RACE data demonstrated that there is an
transcript starting downstream of this promoter sequence (Chapter 3, Figure 8). This
long upstream promoter (22distp) regulates the expression of bbb22 and is required for
the expression of bbb22 (Chapter 3, Figure 9A). Another short sequence promoter,
referred to herein as the proximal promoter (22proxp), was not sufficient to maintain
bbb22 expression to wild type levels (Chapter 3, Figure 9A). It remains unclear how the
long sequence including 22distp upstream of BBB22 ORF regulates bbb22 expression.
Purine transport assays were performed to study the individual roles of BBB22 and
BBB23. Results showed that both the BBB22 and BBB23 are capable of hypoxanthine
uptake but their affinities for the hypoxanthine uptake are different. Uptake of
hypoxanthine by BBB23 alone was only detectable when bbb23 was expressed under a
constitutive promoter, and this transport was still at a slow rate compared to spirochetes
carrying bbb22 alone (Chapter 3, Figure 10). Our data indicate that BBB22 is the more
efficient hypoxanthine transporter compared to BBB23. BBB22 can individually transport
hypoxanthine when expressed under the long upstream sequence including the distal
promoter (22distp) but not under the short upstream sequence including the proximal
promoter (22proxp). In vitro hypoxanthine assay results showed that in the initial stages,
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the hypoxanthine uptake by both transporters individually was siginificantly reduced
compared to the BBB22-23 together. At later time points, BBB22 mediatedhypoxanthine uptake levels were comparable to the hypoxanthine uptake levels of
BBB22-23 together (Chapter 3, Figure 10A). Data from the adenine uptake assays
suggest that BBB22 alone can transport, adenine, but adenine uptake is slow compared
to the BBB22-23 together (Figure 10B). This slow adenine uptake by BBB22 alone
compared to the BBB22-23 together, suggests BBB23 also contributes to adenine
uptake. But, results from adenine uptake assays with spirochetes carrying bbb23 alone
under control of a constitutive promoter did not show any adenine uptake by this clone
at the concentration of adenine examined. These data suggest that BBB23 alone is not
sufficient for the adenine transport or BBB23-dependent adenine uptake is below
detection limits and therefore, BBB22 is required along BBB23 for the adenine uptake.
BBB22 has high affinity for the adenine uptake but BBB22 alone is still not sufficient to
transport adenine to levels similar to BBB22-23 together. So, BBB23 is required along
with BBB22 to achieve wild type levels of adenine uptake.
To confirm if BBB23 does indeed function as an adenine transporter or if only the
bbb23 transcript is needed for the full activity of BBB22 in adenine uptake, competition
assays were performed using the spirochetes harboring only bbb23 under a constitutive
promoter (flaBp-bbb23+). Results clearly show that the uptake of [3H]hypoxanthine in
these spirochetes was significantly reduced in the presence of 20 fold excess unlabeled
adenine (Chapter 3, Figure 11B). So, BBB23 is a purine permease with a low affinity for
adenine uptake. Competition assay results from B. burgdorferi clones harboring only
bbb22 or bbb23 also demonstrated that both BBB22 and BBB23 are guanine
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permeases. Overall these data demonstrate that the BBB22 and BBB23 are both purine
permeases in which BBB22 has higher affinity for the uptake of both adenine and
hypoxanthine compared to BBB23. It has been suggested that there may be insufficient
guanine available in the murine host to allow B. burgdorferi survival [43], so,
hypoxanthine and adenine salvage from the mouse is critical for B. burgdorferi to
synthesize guanine nucleotides and deoxynucleotides during infection.
Our data indicate that BBB22, a high affinity purine transporter compared to the
BBB23, is able to salvage sufficient amounts of adenine and hypoxanthine to allow for B.
burgdorferi survival in the mouse. Because of the low hypoxanthine and adenine uptake
affinities of BBB23, spirochetes harboring only BBB23 were unable to survive in the
mouse. So, bbb22 is critical for mouse infection but bbb23 is not (Chapter 3, Table 5).
Spirochete loads in mouse tissues were determined for the spirochetes harboring bbb22
and were compared with mice inoculated with spirochetes having both bbb22 and
bbb23. We found that the mice inoculated with the spirochetes harboring only bbb22,
showed a significant reduction in spirochete loads in mouse tissues compared to the
spirochete loads for bbb22-23+ spirochetes. The low spirochete loads for bbb22+
spirochetes are believed to be due to the reduced affinity of purine uptake by BBB22
alone compared to BBB22-23. A diminished capacity to salvage purines will result in
decreased nucleotides synthesis for DNA, RNA and the other metabolic processes, and
thus low spirochetes numbers compared to when both the bbb22 and bbb23 are
present. As bbb22 alone is sufficient for mouse infection, it is not clear yet why B.
burgdorferi possesses two purine transporters with seemingly the same function but
different purine uptake affinities. One possible explanation is that due to the complex
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infectious cycle of B. burgdorferi, the availability of the purines may vary with the
change in host environments. So, in some host environments due to low purine
availability, both BBB22 and BBB23 are required for the maximum uptake, whereas in
others with a high abundance of purines, only one or the other purine transporter may
be necessary for the spirochete survival. To be able to study the effects of varying
amounts of purines on the activities of these purine transporters, a defined, minimal
medium would be critical for in vitro growth analysis. At present such an experimental
system does not exist for B. burgdorferi. Future studies are focused on identification of
a defined, minimal medium for growth of B. burgdorferi. An alternate strategy to study
the roles of varying amounts of purines on BBB22 and BBB23 activity is using E. coli
clones expressing bbb22 or bbb23 or both bbb22 and bbb23 together, and an E. coli
minimal media. The amounts of different purines can be controlled manually and it
would be studied that how BBB22 and BBB23 work in the low and high concentrations
of adenine or hypoxanthine or guanine. bbb22 and bbb23 expression will be studied at
different concentration of these purines.
Ticks acquire spirochetes by feeding upon an infected host. Spirochetes persist
in the tick midgut and obtain nutrients from the tick blood meal [50]. As some bacteria
can use red blood cell (RBC) as a source of purine salvage like Plasmodium falciparum
[148], so B. burgdorferi may also obtain nutrients from degraded RBCs found within the
tick midgut. After a blood meal from an infected host, tick larvae molt into nymphs,
which can then transmit spirochetes from the salivary glands to an uninfected host
during a subsequent feeding [2]. To study the combined role of bbb22-23 in spirochete
survival in the tick vector, expression analysis was performed for bbb22 and bbb23 to
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see if B. burgdorferi express both the genes while residing in the tick vector. These data
showed that both bbb22 and bbb23 are expressed in the tick vector with bbb22
expression 4 fold higher than bbb23. This difference may or may not be significant
(Chapter 4, Figure 13). The roles of bbb22-23 were studied in the spirochete survival
and growth in larval and fed ticks. As bbb22-23 mutant spirochetes do not transport
hypoxanthine, the survival and growth of bbb22-23 mutant spirochetes in the tick vector
will likely depend upon the availability of adenine, nucleotides and deoxynucleotides
during blood meal. Our results show that bbb22-23 mutant spirochetes survive in both
larval and nymphal ticks. However, statistically fewer bbb22-23 mutant spirochetes
were detected in fed larvae as compared to the number of bbb22-23+ spirochetes. As
the size of a fed nymph is much bigger compared to a fed larva, this suggests that the
volume of the blood meal and therefore the availability of the purines, nucleotides and
DNA from the degraded blood may be more in fed nymphs. Wild type spirochetes in fed
larvae have access to all these nutrients along with hypoxanthine and guanine but
bbb22-23 mutant spirochetes cannot uptake hypoxanthine. The diminshed availability of
nutrients for the salvage of purines and nucleotides likely accounts for the finding that
bbb22-23 mutant spirochetes replicate to a less number compared to the wild type
spirochetes in fed larvae (Chapter 4, Figure 15A). In fed nymphs due to the possible
larger volume of the blood meal, the nutrients available to the bbb22-23 mutant
spirochetes may be sufficient to allow the spirochetes to replicate to levels equivalent to
bbb22-23+ spirochetes (Chapter 4, Figure 15B). We also found that reintroduction of
bbb23 alone to bbb22-23 mutant spirochetes was sufficient to restore spirochete
replication to wild type levels (Chapter 4, Figure 16). Overall, our data suggest that
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spirochetes have access to more nutrients in the tick blood meal compared to the initial
stages of mouse infection and thus bbb22-23 contribute to but are not essential for
spirochete survival and growth in fed larvae. We also studied if there are any other
unknown genetic mechanisms, which are activated in the bbb22-23 mutant spirochetes
inside the tick vector and to allow the spirochetes to infect mice by tick bite transmission.
Serology studies and spirochete reisolation experiments were done on mice that were
fed upon by bbb22-23 mutants spirochete infected unfed larvae and nymphs. The
bbb22-23 mutant spirochetes were unable to infect mice by tick bite transmission,
indicating that no compensatory mechanisms were activated during the tick to mouse
transmission, which could allow the bbb22-23 spirochetes to survive in the mouse.
Overall, this study has shown that purine transport system in B. burgdorferi is
essential for the mammalian infection. No essential role of BBB22 and BBB23 in B.
burgdorferi survival in tick vector suggests the availability of nutrients in blood meal in
ticks might be more compared to mammalian host and due to that bbb22-23 mutant
spirochetes bypass the requirement of bbb22-23 and grow normal in tick vector;
whereas it is not true in mammalian host.
5.2 Future studies
1) Understanding the mechanisms of gene regulation of bbb22 and bbb23:
Our lab has previously used an In Vivo Expression Technology (IVET) based method to
identify for the first time B. burgdorferi genes that are actively expressed during a
mouse infection [126]. One of the identified in vivo active promoter sequences of B.
burgdorferi, was found to be within the BBB23 ORF sequence. In this thesis, the data
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shows a transcription start site downstream of this in vivo active promoter sequence
contained within the BBB23 ORF sequence. bbb22 expression and function is
dependent on the presence of a long sequence including this in vivo active promoter
sequence upstream of the BBB22 ORF. In constructs lacking this long upstream
sequence bbb22 expression goes down (Chapter 3, Figure 9) and spirochetes carrying
only bbb22 in the absence this upstream sequence lose the ability to transport purines
(Chapter 3, Figure 10). To further investigate this transcript, we performed PCR analysis
using cDNA made from extracted RNA of in vitro grown wild type spirochetes. PCR was
done using various primer sets to determine the length of this new unknown transcript
associated with an in vivo active promoter sequence (Table 8). PCR results showed that
transcription downstream of the in vivo active promoter sequence from BBB23 ORF
sequence at the 3’ end runs into the bbb22 ORF sequence (Figure 17).
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Table 8: Primers used in this study.

Primer

Primer name

Primer sequence

BBB23 ORF (1392)-F

CCCGGGGGATCCTTGAAAATATTTTTAAAC

number
1006

AATAAAAAGGAAAGTTT
1009

BBB23 ORF-Reverse

CCCGGGAAGCTTTTAATAGCCATAAATAAA
TTTAATAATAAAAATTAAGC

1172

BBB22 Start-Rev

GAAATAACAATGTTTCTTTGGATTGAT

1383

BBB23 IVET out 409-Fwd

GAGCAAATTATAAACTCTATTCCGA

1384

BBB23 IVET in 667- Fwd

ATATATGCAATCTTTAATTTAGAAGGTG
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Figure 17. PCR analysis of a transcript across bbb23 and bbb22.
(A) Schematic representation of various primers used to determine intragenic transcript
within bbb23 ORF. Primers used are shown as arrows in black. IVET promoter
sequence site is shown as a start in red. Transcription start site for bbb22 and IVET
promoter within bbb23 ORF are show as arrows in red. (B) PCR analysis of transcript
from IVET promoter. PCR results with primer sets 1383 and 1172, 1384 and 1172 and
1006 and 1009 are shown in figure. cDNA template is used to study transcript from
IVET promoter. RT- represents cDNA control template without reverse transcriptase.
gDNA represents the genomic DNA template, taken as PCR control for primers. gDNArepresents no genomic template as a negative control to determine reagent
contamination.
Future experiments will be done to determine the 3’ end of this transcript by 3’
RACE or walking reverse primer towards 3’ end into bbb22 ORF sequence or
determining transcript size by Northern blot. Once the size of this transcript is known,
then it can be determined if only a small part of this long transcript or the entire
transcript is required for bbb22 expression and function. Future studies investigating the
regulation of bbb22 and bbb23 are focused on understanding the mechanisms involved
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in the regulation of bbb22, specifically by means of this distal promoter sequence
(22distp).
To study the gene regulation of purine permease encoding genes, it is
important to have defined in vitro growth medium. This will allow experimental
examination of expression of the transport genes in the presence of various
concentrations of purines. In the case of B. burgdorferi, BSKII medium is not defined
and is highly rich in nutrients. Due to the complex nature of BSKII medium, it would be
difficult to reduce the purine levels. Another way to study the affect of purine
concentration of the regulation of the purine transport genes could be to add additional
adenine, hypoxanthine or guanine to B. burgdorferi cultures growing in the BSKII
medium. Supplementing the B. burgdorferi cultures with an excess of adenine,
hypoxanthine and guanine and giving sufficient time for spirochetes to grow, could
result in a change in the gene expression of bbb22 and bbb23. B. burgdorferi is
expected to show lower expression levels for bbb22 and bbb23 in the presence of
excess of purines.
It is also important to study bbb22 and bbb23 gene regulation in log and
stationary growth phases of spirochetes because our quantitative PCR analysis for the
gene expression of bbb22 and bbb23 in the wild type spirochetes show that bbb23
expression in log phase spirochetes increases by 36-fold compared to the stationary
phase spirochetes; whereas bbb22 expression does not show a significant difference.
So, identifying the mechanisms involved in the change in gene expression of bbb23 but
not bbb22 under different growth stages, are under investigation. Purine transport
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genes have shown to be controlled by riboswitches by binding of adenine and guanine
to the riboswitch present in 5’ UTR of transport genes. So finding possible riboswitches
in 5’ UTR of bbb22 and bbb23 studying their role in gene regulation is also under
investigation.

2) Using BBB22 and BBB23 as potential therapeutic targets to treat Lyme disease:
BBB22 and BBB23 are purine transporters, which can be used as potential
targets for drug development or drug delivery to prevent the B. burgdorferi growth and
thus to treat Lyme disease. These purine permeases could be used as therapeutic
targets in two ways, 1) delivering antimetabolites through these permeases or 2) using
drugs that inhibit purine permease function [149] (Figure 18). Antimetabolites mimic the
structure the true metabolites and prevent the use of essential metabolites during
metabolism. Antimetabolites such as purine analogues, mimic purines in structure and
will prevent purine incorporation into DNA or RNA. As a result, these antimetabolites will
eventually shut down nucleic acid synthesis. Many of the purine and pyrimidine
antimetabolites approved by FDA are being used as therapeutics [150]. Most of the
purine transporters in microbial organisms are different from the purine transporters in
humans and mammals. So, using these microbial purine transporters as a therapeutic
target may successfully treat the various infectious diseases [77, 79, 151]. Using BBB22
and BBB23 as therapeutic targets may hold a number of possible advantages such as
having the ability to use lower minimum inhibitory concentrations of drugs due to the
drugs being delivered through specific permeases as opposed to the drugs being
delivered through diffusion process, which may require higher concentrations. In
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addition, drug delivery through these permeases will be more specific to kill or inhibit
bacteria but not host cells. Targeting B. burgdorferi through BBB22 and BBB23 will be
helpful to treat Lyme disease more effectively by increasing safety range for drug use
thus expanding therapeutic window.

Figure 18: Use of purine permeases as therapeutic targets.
BBB22-23 purine permeases are shown as yellow oval. Two possible ways to use
BBB22-23 purine transporters as therapeutic targets has been shown. Using BBB22-23
transporters to deliver various antimetabolites such as hypoxanthine, adenine or
guanine analogues are shown as part A. Another way to target BBB22-23 is by
preventing purine uptake in B. burgdorferi by inhibiting BBB22-23 with different purine
permease inhibitors as shown in part B.
Various antimetabolites can be that can be targeted for transport through the B.
burgdorferi purine permeases include purine analogues to hypoxanthine such as
allopurinol, 6-mercaptopurine and 8-aza-2, 6-diaminopurine, purine analogues to
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adenine such as 2-fluroadenine, 6-methyl purine, 2, 6-diaminopurine, 2-aminopurine
and 8-aza-adenine, and purine analogues to guanine such as 6-thioguanine, 8
azoguanine and 2-amino-6-chloropurine. Purine analogues are FDA approved drugs
used to treat cancer and other disease [150, 152]. The E. coli hypoxanthine-guanine
specific purine permease, YjcD, has been shown to be responsible for bacterial
sensitivity to purine analogue toxicity [121]. Using purines permeases to deliver toxic
analogues would therefore aid in the prevention of bacterial infections in the host.
Plasmodium falciparum and Trypanosoma has previously shown to be sensitive to the
toxicity of purine analogues [153, 154]. Similar studies can be performed in B.
burgdorferi to see if the BBB22 and BBB23 purine permeases transport purine
analogues. B. burgdorferi in vitro growth assays can be performed using various
concentrations of these analogues. We preliminarily examined the purine analogues 2fluroadenine, 8-aza-guanine, 6-mercaptopurine and 6-thioguanine to determine if these
molecules are transported through BBB22 and/or BBB23 and are able to inhibit B.
burgdorferi in vitro growth (Table 9).
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Table 9. B. burgdorferi growth inhibition by purine and nucleoside analogues.
Analogues

B. burgdorferi clone

700uMa

70uMa

7uMa

6-mercaptopurine

Wild type

NI

NI

NI

Δbbb22-23/vector

NI

NI

NI

bbb22-23+

NI

NI

NI

Wild type

CI

PI

NI

Δbbb22-23/vector

CI

PI

NI

bbb22-23+

CI

PI

NI

Wild type

NI

NI

NI

Δbbb22-23/vector

NI

NI

NI

bbb22-23+

NI

NI

NI

Wild type

CI

PI

NI

Δbbb22-23/vector

CI

PI

NI

bbb22-23+

CI

PI

NI

Wild type

NI

NI

NI

Δbbb22-23/vector

NI

NI

NI

bbb22-23+

NI

NI

NI

Wild type

PI

NI

NI

Δbbb22-23/vector

PI

NI

NI

bbb22-23+

PI

NI

NI

2-fluoroadenine

8-azaguanine

6-thioguanine

6-Azaxanthine
monohydrate

2-fluoroadenosine

a

CI = Complete Inhibition, PI = Partial Inhibition, NI = No Inhibition
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The growth assay results showed that B. burgdorferi has minimal sensitivity to 2fluoroadenine, 6-thioguanine and 2-fluoroadenosine. We did not see any clear
differences between the wild type and bbb22-23 mutant spirochetes in the toxicity of the
purine analogues tested. It is unclear from these data if BBB22 and BBB23 contribute in
the transport of purine analogues such as 2-fluoroadenine and 6-thioguanine. Our
studies showed that B. burgdorferi do not transport hypoxanthine in the absence of
BBB22 and BBB23, suggesting these are the only high affinity purine transporters in B.
burgdorferi to transport hypoxanthine. Data from adenine uptake assays also suggests
the presence of another unknown adenine transporter/s in B. burgdorferi, but these data
cannot discount another guanine transporter(s) being present in B. burgdorferi apart
from BBB22 and BBB23. Therefore it is possible that BBB22 and BBB23 may transport
these antimetabolites but, if there are other unknown transporters for adenine and
guanine, these could also be responsible for the transport of the purines analogues in B.
burgdorferi. This might be the reason that bbb22-23 mutant spirochetes are also
sensitive to 2-fluoroadenine and 6-thioguanine. 6-mercaptopurine, a hypoxanthine
analogue, was expected to show toxic effects in wild type spirochetes but not in the
bbb22-23 mutant spirochetes because in B. burgdorferi, hypoxanthine is being
transported by BBB22 and BBB23 only. Results show that both types of spirochetes
grow normal in the presence of 6-mercaptopurine and do not show any toxic effects on
in vitro growth. This may be due to either low phosphoribosyltransferase activity for
hypoxanthine in B. burgdorferi [73] or rapid oxidation of mercaptopurine as seen in the
other bacteria such as Pseudomonas aeruginosa [155]. Allopurinol and 8-aza-2,6diaminopurine are the other hypoxanthine analogues, which could additionally be
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studied to see if these are being transported by BBB22 and BBB23 and are toxic only to
the wild type spirochetes but not the bbb22-23 mutant spirochetes. As B. burgdorferi
has a minimal purine salvage pathways lacking many of the enzymes that are involved
in purine salvage pathway. So it is not only important to identify the analogues being
transported by these purine transporters but it is also important to make sure if B.
burgdorferi has enzymes to metabolize these analogues. Identifying such drug
candidates that are transported through BBB22 and BBB23 will further provide
information about the presence of enzymes in B. burgdorferi that act on these
metabolites. These studies will also provide information on if the enzymatic activities of
these enzymes in B. burgdorferi are sufficient to metabolize these antimetabolites and
show toxic effects.

3) Amino acid sequence alignment of BBB22 and BBB23 with other purine transporters
of COG2252 cluster, and identifying putative amino acids essential for the transport
activities of BBB22 and BBB23:
BBB22 and BBB23 are closely identical to each other in amino acid sequence as
well as the number of putative transmembrane domains. It remains unclear as to why
bbb22 expression and its encoded protein activity are high compared to bbb23. We
were unable to detect hypoxanthine and adenine uptake by BBB23 alone in spirochetes
carrying bbb23 expressed under the control of its own promoter. Even when bbb23
expression was increased under the control of a constitutive promoter to the native
bbb22 levels, only minimal hypoxanthine uptake and no adenine uptake by BBB23 were
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detected. This suggested to us to look closely at the amino acid sequence of BBB22
and BBB23 to work to understand the purine permease affinity differences between
BBB22 and BBB23. Amino acid sequence alignment of various purine permeases in
COG2252 such as PurP, YicO, YjcD and YgfQ of E. coli, PbuG and PbuO of Bacillus
subtilis and AzgA of Aspergillus nidulans have some amino acids within its
transmembrane domains that are either fully conserved (dark green) or partial
conserved (light green) [80]. These amino acid positions were determined based upon
the positions of fully conserved or partial conserved amino acids in well studied purine
permeases of COG2233 cluster [80]. COG2233 cluster belongs to nuclebase cation
symporter 2 (NCS2) superfamily and includes well studied xanthine and/or uric acid
permeases. Conservation of these amino acids occurs between the members of
COG2252, but the members of COG2233 are well conserved for amino acid residues at
same locations among their members but are distinct from the COG2252 members.
Point mutations in these conserved amino acids of COG2252 members has identified
key residues critical for hypoxanthine, adenine, and guanine uptake activity [80]. We
have found that amino acid sequence alignment of BBB22 and BBB23 with other
members of COG2252 cluster using the ClustalW algorithm show that both BBB22 and
BBB23 also possess these fully conserved (shown as dark green) and the partially
conserved (light green) amino acid residues (Figure 19). These residues are expected
to play important roles in the substrate specificity and binding affinity as seen in the
purine permeases in E. coli [80]. Interestingly, we have found that residues of BBB22
and BBB23 corresponding to residue 271 of PurP show a change in the amino acid
residue from a threonine in BBB22 similar to the other members of COG2252, to an
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isoleucine in BBB23 (Figure 19). It has been studied that threonine in YjcD corresponds
to residue 271 of PurP is required for hypoxanthine/guanine transport. We speculate
that differences in the activities of BBB22 and BBB23 may be due, in part, to the
difference in this residue. Future experiments include point mutations to replace the
isoleucine in BBB23 with a threonine and perform purine transport assays with these
mutation clones. We hypothesize that BBB23 transport activity will increase after
replacement of the key isoleucine with threonine.

Figure 19. BBB22 and BBB23 show amino acid variation at one of the conserved
residues.
Amino acid sequences of BBB22 and BBB23 were aligned with other members of
COG2252 cluster using Clustal W method. Sequence alignment of transmembrane
loops is shown as TM. Conserved amino acids are highlighted as dark green and semiconserved amino acids as light green. Residue numbers refer to PurP purine
transporter in E. coli [80]. BBB23 amino acid Isoleucine in Transmembrane 8, varies
from BBB23 and other members of COG2252 cluster, is shown in red.
5.3 Final conclusion
Collectively, we have identified a purine transport system in B. burgdorferi, which
is essential for B. burgdorferi-mammalian infection. Identification such a purine transport
system in B. burgdorferi, and genetic and biochemical characterization of the roles of
these purine transporters in the infectious cycle of B. burgdorferi improves our
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understanding of the essential molecular mechanisms involved in the virulence of this
Lyme disease pathogen. Based upon our experimental data, we hypothesize a putative
amino acid residue in BBB23 that is responsible for its low transport activity compared
to BBB22.
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